The invention generally relates to cell and tissue culture devices.
While certain tissues in the human body, such as skin, are capable of self-repair (e.g., wound healing), there are many tissues that are not. For example, articular cartilage has no innate ability to repair itself, rendering any damage thereto permanent. Articular cartilage lines opposing bone surfaces in diarthrodial joints and provides a smooth, lubricated surface for articulation. Accordingly, defects in articular cartilage tend to expand and worsen over time. Damage to the articular cartilage in joints such as the knee can lead to debilitating pain.
Typical treatment choices, depending on lesion and symptom severity, are rest and other conservative treatments, minor arthroscopic surgery to clean up and smooth the surface of the damaged cartilage area, and other surgical procedures such as microfracture, drilling, and abrasion. All of these may provide symptomatic relief, but the benefit is usually only temporary, especially if the person's pre-injury activity level is maintained. For example, severe and chronic forms of knee joint cartilage damage can lead to greater deterioration of the joint cartilage and may eventually lead to a total knee joint replacement. Approximately 200,000 total knee replacement operations are performed annually. The artificial joint generally lasts only 10 to 15 years and the operation is, therefore, typically not recommended for people under the age of fifty.
An alternative treatment is implantation of cultured neo-cartilage (i.e., immature hyaline cartilage) which can be grown in-vitro to a desired size and shape on a 3D scaffold from chondrocyte cells biopsied from the patient (autologous) or from another individual (heterologous). Examples of this process are described, for example, in U.S. Pat. Nos. 6,949,252; 7,537,780; 7,468,192; 7,217,294; and U.S. patent application Ser. No. 14/208,931. An exemplary method for 3D culture of neo-cartilage is shown in
Along with the neo-cartilage for implantation, multiple other surrogate tissues are simultaneously cultured in the same vessel in order to permit pre-implantation testing and verification procedures without damaging the neo-cartilage to be implanted.
Current culture containers include narrow opening flask-type containers with a sealing cap with a gas-permeable filter membrane but the 3D static culture procedure presents multiple challenges which are unmet by current culture containers. For example, the surrogates and the neo-cartilage to be implanted need to be cultured in the same conditions in a common fluid to enable validation through surrogate testing. However, in current containers, the surrogates and neo-cartilage can grow into one another as they mature and then require separation which can damage the cells and scaffolds. Another problem stems from the fact that the tissues must be submerged in fluid during the 3D static culture but the buoyancy of the cultures varies during tissue growth. The 3D static culture process takes 2 weeks and requires incubation throughout the process, taking up space in expensive incubators and limiting production efficiency and capacity using bulky flask-type containers. Additionally, the surrogates and the neo-cartilage to be implanted must be transferred from one container to another during the 2 week process and then must be removed from the container before final packaging for distribution and implantation. Manipulation of the neo-cartilage to be implanted and the surrogates through the narrow opening of the current culture containers is difficult and can cause damage to the cells. These challenges are not unique to 3D static culturing of neo-cartilage and apply to a variety of cell and tissue culturing procedures.
The invention relates to containers for cell and tissue culturing with multiple compartments in fluid communication with each other to provide a common culture environment in each of the compartments while maintaining physical separation of cells and tissue therein. Culture containers of the invention can be used to simultaneously culture one or more surrogate tissues alongside and under the same conditions as a tissue to be implanted, thereby enabling destructive testing and verification procedures to be carried out without harming the tissue to be implanted. Each compartment may contain the same type of tissue or different tissue types in order to investigate interactions between different tissue types. In some instances multiple tissue types may be cultured in a single compartment. The containers of the present invention provide containers for culturing these tissues in a common environment and fluid while preventing the surrogate tissues and the tissue for implantation from adhering or growing onto the container or each other and potentially damaging the tissue for implantation. Containers of the invention may provide sealing lids with gas permeable membranes to allow for gas exchange between the interior and exterior environments of the container while maintaining a sterile internal environment. The culture containers and lids may be configured to minimize height while maintaining adequate interior volume and maximizing incubator efficiency and space. Containers of the invention may also provide multiple compartments in fluid communication yet capable of restricting movement of and various sizes of sometimes buoyant tissue cultures and other materials. Additionally, culture containers of the invention may provide a large opening with easy, lid-off access to each compartment and any tissue or other materials therein. The several features of the containers of invention provide a more efficient platform for culturing and verifying cells and tissues for implantation while minimizing the potential for damage to the implantable tissue.
Culture containers of the invention may comprise a bottom wall and at least one side wall coupled thereto. Side walls may form right angles with the bottom wall or may taper out to provide a large opening with easy access to the compartments therein. Culture containers can be a cylinder, a cuboid, a triangular prism, a pentagonal prism, an octagonal prism or a variety of other 3 dimensional shapes.
Containers of the invention may include one or more interior walls which can divide the interior volume of the container into two or more compartments. A container may have 11 or more compartments or as few as two. The compartments may be of the same size or a variety of sizes. In some instances a larger compartment may be configured to contain cultured tissue for implantation while several smaller compartments may be sized to contain surrogates for testing.
In certain aspects, the container may comprise multiple components such as a first unit comprising a bottom wall and at least one side wall and a second unit comprising one or more of the interior walls or partition so that the partition may be removed from the container providing a single compartment or inserted into the container to provide multiple compartments therein. In certain instances, a single first component comprising the one or more side walls and the bottom wall may be compatible with multiple different second components comprising interior walls in various configurations so that, by interchanging second components, the number of compartments may be varied.
In order to achieve fluid communication between the compartments of the container, the interior walls may have openings including pores, slits, or gaps between an interior wall and a side wall, the bottom wall, or the lid. The openings may be dimensioned so as to allow fluid to pass between the compartments of the container without allowing cells, tissues, or 3D scaffolds to pass therebetween. Screens or filters may be used to cover openings in order to help restrict passage of cells, tissues, or 3D scaffolds therethrough.
Devices of the invention may include a lid configured to detachably couple to the top edge of the one or more side walls in order to enclose the container. The lid can generally correspond in shape and size to the opening formed by the top edge of the one or more side walls. The lid may be configured to form an air or water-tight seal when detachably coupled to the container, may include a gasket to aid in sealing, and may be secured via complementary threads, interlocking tabs, or other means. Preferably, the lid and the container may be detachably coupled without the use of tools in order to promote sterility and relatively easily in order to avoid excessive motion of the contained fluid and disruption of the cultured materials.
The lid may comprise a vent and/or a gas permeable membrane of a size and shape configured to allow gas to pass into and out of a sealed container while restricting undesirable particles such as bacteria, endotoxins, and other contaminants. The lid may be configured so that, when detachably coupled to the container, the only avenue for gas exchange between the interior and exterior of the container is through the filter. A filter may also be located on a side wall of the container.
Containers of the invention may be sized so that containers may contain an adequate volume of fluid (e.g., 500 mL) while maintaining sufficient space between the fluid and the lid to avoid contact during movement of the container and so that multiple containers can fit on a standard incubator tray to maximize space efficiency during the incubation process.
The lid, the container, or components thereof may comprise a variety of materials including, for example, polypropylene, high-density polyethylene, polystyrene, styrene-acrylonitrile (SAN), polycarbonatestyrene-maleic anhydride (SMA), cyclic olefin copolymers (COC), acrylic, acrylic-polyvinyl chloride alloys, polypropylene copolymers, polysulfone, polymethylpentene, or cellulosic. The lid, the container, or components thereof may comprise a substantially transparent material to allow visual inspection of the container's contents from outside of the container. Containers and lids may be configured as single-use disposables or may be configured for repeated use and sterilization.
In some aspects, the interior surface of the bottom wall, the interior surface of the one or more side walls, and/or the surfaces of the one or more interior walls may be smooth; textured with ridges, valleys, pores, or dimples; and/or treated with an agent to deter adherence of cultured cells or tissues and/or the facilitate retrieval from the container by scooping under the cultured tissue with a retrieval tool.
The invention relates to culture containers comprising multiple compartments configured to be in fluid communication with each other while maintaining physical separation of cell or tissues being cultured therein. Cells and tissues are cultured on 3D scaffolds to form tissues of a desired shape and size. If a tissue is being cultured for implantation, it is advantageous to simultaneously culture one or more surrogate tissues under the same conditions to enable destructive testing and verification procedures to be carried out without harming the tissue to be implanted. The containers of the present invention provide containers for culturing these tissues in a common environment and fluid while preventing the surrogate tissues and the tissue for implantation from adhering or growing onto the container or each other and potentially damaging the tissue for implantation. In various embodiments, each compartment in a container may contain the same type of tissue or different tissue types in order to investigate effects of different types of tissue on each other in a shared culture environment. In certain instances multiple tissue types may be cultured in a single compartment to investigate physical interactions between the tissues. Culture containers of the invention may be used to culture a variety of cells and tissues including chondrocytes, mesenchymal stem cells, fibroblasts, osteocytes, osteoblasts, synoviocytes, induced pluripotent stem cells (iPSC), embryonic stem cells (ESC), lymphocytes, adipocytes, myofibroblasts, hepatocytes, islet cells, monocytes, endometrial regenerative cells, or cancer stem cells. Applications for these containers include the culturing of neo-cartilage from chondrocytes for repair of articular cartilage defects.
Culture containers of the invention may comprise a bottom wall and at least one side wall coupled thereto. Side walls can be coupled to the bottom wall so that the side wall's planar surface is substantially transverse to the planar surface of the bottom wall. The culture container may have any number of side walls including 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 side walls. Side walls may be substantially straight or may be curved. The bottom wall may be a variety of shapes including, rectangular, circular, triangular, or pentagonal. The bottom wall shape should correspond to the number of side walls. For example, a container 101 with circular bottom wall 105 would comprise a single side wall 109, with a curved planar surface so that the bottom edge of the single side wall 109 forms a circle of substantially equal radius to that of the bottom wall 105 to which it is coupled as shown in
Containers of the invention may include one or more interior walls which can divide the interior volume of the container into two or more compartments. Interior walls may be curved or straight and can be coupled to the bottom wall so that their planar surface is substantially transverse to the planar surface of the bottom wall. Interior walls can be coupled to the same planar surface of the bottom wall as the side walls. Interior walls may be coupled to one or more side walls and/or one or more other interior walls. A culture container may have any number of interior walls, including 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 interior walls and may comprise any number of compartments including 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 compartments.
The larger center compartment 103 of the containers 101 shown in
In certain aspects, the container may comprise multiple components such as a first unit comprising a bottom wall and at least one side wall and a second unit comprising one or more of the interior walls or partition so that the partition may be removed from the container providing a single compartment or inserted into the container to provide multiple compartments therein. One or more of the components may have slots or other physical mechanisms configured to accept a portion of the other component.
In certain instances, a single first component comprising the one or more side walls and the bottom wall may be compatible with multiple different second components comprising interior walls in various configurations so that, by interchanging second components, the number of compartments may be varied.
The first component may include a stop 125 as illustrated in
In order to achieve fluid communication between the compartments of the container, the interior walls may have openings. In certain embodiments the openings may be dimensioned so as to allow fluid to pass between the compartments of the container without allowing cells, tissues, or 3D scaffolds to pass therebetween. In some aspects an interior wall may be perforated with one or more holes or pores. In such instances, each hole should have a diameter smaller than the largest dimension of the cell, tissue, or 3D scaffold being cultured within a compartment defined in part by that interior wall. For example, for 3D tissue culture scaffolds having a 4 mm diameter by 1.5 mm thickness, openings in the interior walls may have diameters less than 4 mm as the scaffolds should be unable to pass through an opening with a diameter less than 4 mm. In certain aspects, an interior wall may comprise a slit of a certain length and width. In such instances, one of the length or the width of the slit should be less than the smallest dimension of the cell, tissue, or 3D scaffold being cultured within a compartment defined in part by that interior wall. For example, using 3D tissue culture scaffolds having a 4 mm diameter by 1.5 mm thickness, the length or width of the slit may be any value so long as the other dimension is less than 1.5 mm.
Openings may be located at a variety of positions within an interior wall including near the center, top, or sides of an interior wall. Openings may be uniformly or differentially located on each interior wall. In certain instances, an opening in an interior wall may be located near the bottom wall of the container. Cell and tissue cultures may rest on the bottom wall of the container during the culturing process. Openings near the bottom wall can allow for the exchange, between compartments, of fluid, nutrients, growth factors, and other particles at the tissue level. Particles that may tend to settle to the bottom may be better exchanged through openings near the bottom wall, thus better replicating the culture environment across compartments.
Interior walls and side walls may be substantially the same height relative to the bottom wall. In some aspects, the interior walls may have a height, relative to the bottom wall, that is less than the height of the side wall, relative to the bottom wall. In such instances, cell-culture medium or other fluid may be added to the container to a level, h, greater than the height of the interior walls but less than the height of the side walls so that the compartments are in fluid communication with each other. In certain aspects, one or more of the interior walls may be coupled to the side walls but not coupled to the bottom wall, leaving a gap between the bottom edge of the one or more interior walls and the planar surface of the bottom wall. This gap can be sized to allow fluid to pass between the compartments of the container without allowing cells, tissues, or 3D scaffolds to pass therebetween. In multi-component embodiments such as illustrated in
In certain embodiments, devices of the invention include a lid configured to detachably couple to the top edge of the one or more side walls in order to enclose the container. The lid can generally correspond in shape and size to the bottom wall. In embodiments where the one or more side walls taper in or out from the edges of the bottom wall, the lid may be smaller or larger than the bottom wall and can generally correspond to the shape and size formed by the top edge of the one or more side walls. The lid may be configured to form an air or water-tight seal when detachably coupled to the container. In certain aspects, a lid and a container may comprise complementary or interlocking threads so that the lid may be screwed down onto the upper edge of the at least one side wall. In some embodiments the lid or the upper edge of the at least one side wall may comprise a recess configured to accept a gasket wherein the gasket is compressed when the lid is detachably coupled to the container and may thereby form a seal. The gasket may be constructed from any suitable material including rubber, plastic, metal, nylon, neoprene, or cork. In certain aspects, a lid may detachably couple to a container through engagement of interlocking tabs on the lid and container. Interlocking tabs may include snap-fit style cantilever prong and recess type connections as well as screw-type interlocking tabs.
In certain aspects, the one or more side walls of a container may be coupled to the bottom wall of the container at substantially right angles and/or the container configured so that the opening at the top of the container has an area substantially equal to the area of the bottom wall. An opening may thusly be configured to provide unfettered access to each compartment within the container from directly above to facilitate manipulation of materials within each compartment without interference from a tapered or flask-like neck or opening.
In some aspects, a lid may comprise a vent and/or a gas permeable membrane of a size and shape configured to allow gas to pass into and out of a sealed container while restricting undesirable particles such as bacteria, endotoxins, and other contaminants. The lid may be configured so that, when detachably coupled to the container, the only avenue for gas exchange between the interior and exterior of the container is through the filter. The filter may have a variety of reference pore sizes including 0.2 to 3 gm such as 0.2, 0.5, 1, 1.5, 2, 2.5, or 3 gm. The filter may be of a variety of different materials such as cellulose, nylon, polytetrafluorethylene, polydimethylsiloxane (PDMS silicone), or glass fiber. Commercially available filter materials include, for example, ePTFE membrane from W. L. Gore & Associates, Inc., 555 Paper Mill Road, Newark, Del. 19711. A filter may also be located on a side wall of the container.
In certain embodiments, a container of the invention may be sized so that multiple containers may fit on a 7 inch by 14 inch incubator tray. A container may be sized to contain a certain volume of fluid including at least 1, 10, 50, 100, 250, 500, 750, or 1000 mL. In an exemplary embodiment, a container 101 of the type illustrated in
In certain embodiments, the lid, the container, or components thereof may comprise a variety of materials. Materials may be biocompatible, endotoxin-free, and/or configured to be sterilized to a variety of Sterility Assurance Levels (SAL) including 10−1, 10−2, 10−3, 10−4, 10−5, or 10−6, for example. In some embodiments, the lid, container, and/or components thereof may comprise a USP Class N, V, or VI material, including, for example, polypropylene, high-density polyethylene, polystyrene, styrene-acrylonitrile (SAN), polycarbonatestyrene-maleic anhydride (SMA), cyclic olefin copolymers (COC), acrylic, acrylic-polyvinyl chloride alloys, polypropylene copolymers, polysulfone, polymethylpentene, or cellulosic. The lid, the container, or components thereof may comprise a substantially transparent material to allow visual inspection of the container's contents from outside of the container. Containers and lids may be configured as single-use disposables or may be configured for repeated use and sterilization. Containers and lids can comprise materials which are nonreactive to standard cell culture media such as EMEM or DMEM.
In some aspects, the interior surface of the bottom wall, the interior surface of the one or more side walls, and/or the surfaces of the one or more interior walls may be smooth; textured with ridges, valleys, pores, or dimples; and/or treated with an agent to deter adherence of cultured cells or tissues and/or the facilitate retrieval from the container by scooping under the cultured tissue with a retrieval tool. In certain aspects, the interior surface of the side walls, interior walls, and/or bottom wall, may be treated with an anti-microbial agent or other instrument to prevent microbial growth and/or contamination.
The lid, the container, or components thereof may be produced by a variety of known means including extrusion, injection molding, blow molding, or rotational molding. The container may be formed from a single piece of material or from multiple pieces which are subsequently coupled together. The lid may be similarly formed. Where constructed from multiple pieces, the pieces maybe joined a variety of known techniques including welding, or bonding using a bonding agent such as a biocompatible adhesive.
In a preferred embodiment, the lid, container, or components thereof are made using thermoforming. In thermoforming, a sheet of material, such as polystyrene is heated until pliable and then formed to a desired shape using a mold. Vacuum pressure may be used to conform the material to the mold. The material may then be cooled to regain rigidity, and then removed from the mold. The resulting product may then be trimmed or otherwise finished to remove excess material or rough edges.
In some aspects, the lid, container, or portions thereof may be formed using injection molding. In injection molding, a mold block with a hollow cavity in shape of the desired product is coupled to a reservoir that can inject molten plastic resin is made. The mold is made in two halves such that a completed part can be removed from one of the halves without any portion being impeded by portions of the mold cavity. The mold is placed in a processing machine capable of clamping the two halves of the mold together. Molten plastic resin is injected into the cavity at high pressure in order to facilitate rapidly filling thin or distant volumes of the mold.
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.
Various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including references to the scientific and patent literature cited herein. The subject matter herein contains important information, exemplification and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof.
This application is a divisional of U.S. patent application Ser. No. 14/558,080, filed Dec. 2, 2014, which is herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3400199 | Balassa | Sep 1968 | A |
3476855 | Balassa | Nov 1969 | A |
3478146 | Balassa | Nov 1969 | A |
3551566 | Thiels | Dec 1970 | A |
3772432 | Balassa | Nov 1973 | A |
3791930 | Saxholm | Feb 1974 | A |
3867728 | Stubstad et al. | Feb 1975 | A |
3966908 | Balassa | Jun 1976 | A |
4060081 | Yannas et al. | Nov 1977 | A |
4172128 | Thiele | Oct 1979 | A |
4182655 | Hartmeier | Jan 1980 | A |
4201845 | Feder et al. | May 1980 | A |
4280954 | Yannas et al. | Jul 1981 | A |
4296100 | Franco | Oct 1981 | A |
4350629 | Yannas et al. | Sep 1982 | A |
4378347 | Franco | Mar 1983 | A |
4394370 | Jefferies | Jul 1983 | A |
4400833 | Kurland | Aug 1983 | A |
4442655 | Stroetmann | Apr 1984 | A |
4448718 | Yannas et al. | May 1984 | A |
4458678 | Yannas et al. | Jul 1984 | A |
4479271 | Botesky et al. | Oct 1984 | A |
4501289 | Bagby | Feb 1985 | A |
4505286 | Yannas et al. | Mar 1985 | A |
4522753 | Yannas et al. | Jun 1985 | A |
4522811 | Eppstein et al. | Jun 1985 | A |
4582865 | Balazs et al. | Apr 1986 | A |
4600574 | Lindner et al. | Jul 1986 | A |
4609551 | Caplan et al. | Sep 1986 | A |
4627853 | Campbell et al. | Dec 1986 | A |
4642120 | Nevo et al. | Feb 1987 | A |
4656137 | Balassa | Apr 1987 | A |
4681763 | Nathanson et al. | Jul 1987 | A |
4683195 | Mullis et al. | Jul 1987 | A |
4683202 | Mullis | Jul 1987 | A |
4713448 | Balazs et al. | Dec 1987 | A |
4736866 | Leder et al. | Apr 1988 | A |
4757017 | Cheung | Jul 1988 | A |
4776173 | Kamarei et al. | Oct 1988 | A |
4776853 | Klement et al. | Oct 1988 | A |
4795467 | Piez et al. | Jan 1989 | A |
4801299 | Brendel et al. | Jan 1989 | A |
4837379 | Weinberg | Jun 1989 | A |
4846835 | Grande | Jul 1989 | A |
4851354 | Winston et al. | Jul 1989 | A |
4870009 | Evans et al. | Sep 1989 | A |
4873191 | Wagner et al. | Oct 1989 | A |
4873192 | Kunkel | Oct 1989 | A |
4880429 | Stone | Nov 1989 | A |
4880610 | Constantz | Nov 1989 | A |
4902508 | Badylak et al. | Feb 1990 | A |
4904259 | Itay | Feb 1990 | A |
4912032 | Hoffman et al. | Mar 1990 | A |
4932973 | Gendler | Jun 1990 | A |
4950296 | McIntyre | Aug 1990 | A |
4950483 | Ksander et al. | Aug 1990 | A |
4955911 | Frey et al. | Sep 1990 | A |
4963146 | Li | Oct 1990 | A |
4963489 | Naughton et al. | Oct 1990 | A |
4965188 | Mullis et al. | Oct 1990 | A |
4971954 | Brodsky et al. | Nov 1990 | A |
4976738 | Frey et al. | Dec 1990 | A |
4978355 | Frey et al. | Dec 1990 | A |
4981783 | Augenlicht | Jan 1991 | A |
4994559 | Moscatelli et al. | Feb 1991 | A |
5002071 | Harrell | Mar 1991 | A |
5002583 | Pitaru et al. | Mar 1991 | A |
5007934 | Stone | Apr 1991 | A |
5010892 | Colvin et al. | Apr 1991 | A |
5032508 | Naughton et al. | Jul 1991 | A |
5041138 | Vacanti et al. | Aug 1991 | A |
5053049 | Campbell | Oct 1991 | A |
5053050 | Itay | Oct 1991 | A |
5067963 | Khouri et al. | Nov 1991 | A |
5067964 | Richmond et al. | Nov 1991 | A |
5071436 | Huc et al. | Dec 1991 | A |
5073373 | O'Leary et al. | Dec 1991 | A |
5084051 | Tormala et al. | Jan 1992 | A |
5087963 | Kaneda et al. | Feb 1992 | A |
5092867 | Harms et al. | Mar 1992 | A |
5092887 | Gendler | Mar 1992 | A |
5118512 | O'Leary et al. | Jun 1992 | A |
5152791 | Hakamatsuka et al. | Oct 1992 | A |
5155214 | Baird et al. | Oct 1992 | A |
5191067 | Lappi et al. | Mar 1993 | A |
5195892 | Gersberg | Mar 1993 | A |
5206023 | Hunziker | Apr 1993 | A |
5206028 | Li | Apr 1993 | A |
5226914 | Capian et al. | Jul 1993 | A |
5227147 | Yoshimura et al. | Jul 1993 | A |
5236456 | O'Leary et al. | Aug 1993 | A |
5256140 | Fallick | Oct 1993 | A |
5256476 | Tanaka et al. | Oct 1993 | A |
5260420 | Burouf-Radosevich et al. | Nov 1993 | A |
5270197 | Yayon et al. | Dec 1993 | A |
5270300 | Hunziker | Dec 1993 | A |
5275826 | Badylak et al. | Jan 1994 | A |
5281265 | Liu | Jan 1994 | A |
5281422 | Badylak et al. | Jan 1994 | A |
5284155 | Treadwell et al. | Feb 1994 | A |
5290558 | O'Leary et al. | Mar 1994 | A |
5298254 | Prewett et al. | Mar 1994 | A |
5302702 | Seddon et al. | Apr 1994 | A |
5306304 | Gendler | Apr 1994 | A |
5306311 | Stone et al. | Apr 1994 | A |
5306500 | Rhee et al. | Apr 1994 | A |
5310883 | Seddon et al. | May 1994 | A |
5314476 | Prewett et al. | May 1994 | A |
5326357 | Kandel | Jul 1994 | A |
5329846 | Bonutti | Jul 1994 | A |
5336616 | Livesey et al. | Aug 1994 | A |
5338772 | Bauer et al. | Aug 1994 | A |
5352463 | Badylak et al. | Oct 1994 | A |
5352589 | Bergonzoni et al. | Oct 1994 | A |
5354557 | Oppermann et al. | Oct 1994 | A |
5356629 | Sander et al. | Oct 1994 | A |
5356883 | Kuo et al. | Oct 1994 | A |
5368858 | Hunziker | Nov 1994 | A |
5372821 | Badylak et al. | Dec 1994 | A |
5380328 | Morgan | Jan 1995 | A |
5410016 | Hubbell et al. | Apr 1995 | A |
5411885 | Marx | May 1995 | A |
5425769 | Snyders, Jr. | Jun 1995 | A |
5439684 | Prewett et al. | Aug 1995 | A |
5439818 | Fiddes et al. | Aug 1995 | A |
5443950 | Naughton et al. | Aug 1995 | A |
5445833 | Badylak et al. | Aug 1995 | A |
5464439 | Gendler | Nov 1995 | A |
5466462 | Rosenthal et al. | Nov 1995 | A |
5471893 | Newbigging | Dec 1995 | A |
5474987 | Cohen et al. | Dec 1995 | A |
5475052 | Rhee et al. | Dec 1995 | A |
5491220 | Seddon et al. | Feb 1996 | A |
5496722 | Goodwin et al. | Mar 1996 | A |
5507813 | Dowd et al. | Apr 1996 | A |
5510396 | Prewett et al. | Apr 1996 | A |
5512460 | Nauro et al. | Apr 1996 | A |
5513682 | Morse et al. | May 1996 | A |
5516532 | Atala et al. | May 1996 | A |
5516533 | Badylak et al. | May 1996 | A |
5522753 | McGraw | Jun 1996 | A |
5545222 | Bonutti | Aug 1996 | A |
5549904 | Juergensen et al. | Aug 1996 | A |
5554389 | Badylak et al. | Sep 1996 | A |
5556430 | Gendler | Sep 1996 | A |
5565519 | Rhee et al. | Oct 1996 | A |
5569272 | Reed et al. | Oct 1996 | A |
5569584 | Augenlicht | Oct 1996 | A |
5571721 | Turner | Nov 1996 | A |
5571895 | Kurokawa et al. | Nov 1996 | A |
5576288 | Lappi et al. | Nov 1996 | A |
5604293 | Fiddes et al. | Feb 1997 | A |
5606793 | Gross et al. | Mar 1997 | A |
5607474 | Athanasiou et al. | Mar 1997 | A |
5614496 | Dunstan et al. | Mar 1997 | A |
5614587 | Rhee et al. | Mar 1997 | A |
5616568 | Pouyani et al. | Apr 1997 | A |
5618551 | Tardy et al. | Apr 1997 | A |
5618925 | Dupont et al. | Apr 1997 | A |
5622928 | Naruo et al. | Apr 1997 | A |
5624463 | Stone et al. | Apr 1997 | A |
5629191 | Cahn | May 1997 | A |
5630842 | Brodniewicz | May 1997 | A |
5630982 | Boring | May 1997 | A |
5631011 | Wadstrom | May 1997 | A |
5632745 | Schwartz | May 1997 | A |
5650176 | Lee et al. | Jul 1997 | A |
5653730 | Hammerslag | Aug 1997 | A |
5656492 | Glowacki et al. | Aug 1997 | A |
5656598 | Dunstan et al. | Aug 1997 | A |
5662710 | Bonutti | Sep 1997 | A |
5676976 | Lee et al. | Oct 1997 | A |
5679637 | Lappi et al. | Oct 1997 | A |
5681353 | Li et al. | Oct 1997 | A |
5683461 | Lee et al. | Nov 1997 | A |
5686431 | Cohen et al. | Nov 1997 | A |
5695998 | Badylak et al. | Dec 1997 | A |
5700476 | Rosenthal et al. | Dec 1997 | A |
5700774 | Hattersley et al. | Dec 1997 | A |
5707962 | Chen et al. | Jan 1998 | A |
5713374 | Pachence et al. | Feb 1998 | A |
5718413 | Walter et al. | Feb 1998 | A |
5723331 | Tubo et al. | Mar 1998 | A |
5728159 | Stroever et al. | Mar 1998 | A |
5733337 | Carr, Jr. et al. | Mar 1998 | A |
5733564 | Lehtinen | Mar 1998 | A |
5736132 | Juergensen et al. | Apr 1998 | A |
5736372 | Vacanti et al. | Apr 1998 | A |
5736396 | Bruder et al. | Apr 1998 | A |
5749874 | Schwartz | May 1998 | A |
5755791 | Whitson et al. | May 1998 | A |
5759190 | Vibe-Hansen et al. | Jun 1998 | A |
5763416 | Bonadio et al. | Jun 1998 | A |
5769899 | Schwartz et al. | Jun 1998 | A |
5770229 | Tanihara et al. | Jun 1998 | A |
5770417 | Vacanti et al. | Jun 1998 | A |
5782835 | Hart et al. | Jul 1998 | A |
5782915 | Stone | Jul 1998 | A |
5786217 | Tubo et al. | Jul 1998 | A |
5788625 | Plouhar et al. | Aug 1998 | A |
5800537 | Bell | Sep 1998 | A |
5814084 | Grivas et al. | Sep 1998 | A |
5824055 | Spiridigliozzi et al. | Oct 1998 | A |
5830493 | Yokota et al. | Nov 1998 | A |
5837458 | Minshull et al. | Nov 1998 | A |
5837534 | Olson et al. | Nov 1998 | A |
5842477 | Naughton et al. | Dec 1998 | A |
5846931 | Hattersley et al. | Dec 1998 | A |
5853746 | Hunziker | Dec 1998 | A |
5855620 | Bishopric et al. | Jan 1999 | A |
5859208 | Fiddes et al. | Jan 1999 | A |
5863296 | Orton | Jan 1999 | A |
5863297 | Walter et al. | Jan 1999 | A |
5863792 | Tyndorf et al. | Jan 1999 | A |
5868415 | Villeneuve | Feb 1999 | A |
5874417 | Prestwich et al. | Feb 1999 | A |
5878444 | Lai | Mar 1999 | A |
5878452 | Athanasiou et al. | Mar 1999 | A |
5881733 | Stone | Mar 1999 | A |
5888219 | Bonutti | Mar 1999 | A |
5893888 | Bell | Apr 1999 | A |
5899936 | Goldstein | May 1999 | A |
5899939 | Boyce et al. | May 1999 | A |
5902741 | Purchio et al. | May 1999 | A |
5904716 | Gendler | May 1999 | A |
5906827 | Khouri et al. | May 1999 | A |
5908837 | Cohen et al. | Jun 1999 | A |
5908924 | Burdette et al. | Jun 1999 | A |
5910315 | Stevenson et al. | Jun 1999 | A |
5916285 | Hu | Jun 1999 | A |
5916557 | Berlowitz-Tarrant et al. | Jun 1999 | A |
5922028 | Plouhar et al. | Jul 1999 | A |
5928945 | Seliktar et al. | Jul 1999 | A |
5942496 | Bonadio et al. | Aug 1999 | A |
5948429 | Bell et al. | Sep 1999 | A |
5949252 | Taguchi | Sep 1999 | A |
5952191 | Morozov | Sep 1999 | A |
5955438 | Pitaru et al. | Sep 1999 | A |
5964805 | Stone | Oct 1999 | A |
5965125 | Mineau-Hanschke | Oct 1999 | A |
5972385 | Liu et al. | Oct 1999 | A |
5972388 | McKay | Oct 1999 | A |
5974663 | Ikeda et al. | Nov 1999 | A |
5976524 | Hammerman | Nov 1999 | A |
5989269 | Vibe-Hansen et al. | Nov 1999 | A |
5989289 | Coates et al. | Nov 1999 | A |
5989866 | Deisher et al. | Nov 1999 | A |
5998170 | Arakawa et al. | Dec 1999 | A |
6001352 | Boyan et al. | Dec 1999 | A |
6005161 | Brekke et al. | Dec 1999 | A |
6013853 | Athanasiou et al. | Jan 2000 | A |
6015711 | Olson et al. | Jan 2000 | A |
6017348 | Hart et al. | Jan 2000 | A |
6022744 | Tetteroo et al. | Feb 2000 | A |
6025334 | Dupont et al. | Feb 2000 | A |
6025538 | Yaccarino, III | Feb 2000 | A |
6027742 | Lee et al. | Feb 2000 | A |
6027743 | Khouri et al. | Feb 2000 | A |
6027744 | Vacanti et al. | Feb 2000 | A |
6030635 | Gertzman et al. | Feb 2000 | A |
6037171 | Larsson | Mar 2000 | A |
6039762 | McKay | Mar 2000 | A |
6042610 | Li et al. | Mar 2000 | A |
6056777 | McDowell | May 2000 | A |
6060640 | Pauley et al. | May 2000 | A |
6074663 | Delmotte et al. | Jun 2000 | A |
6080194 | Pachence et al. | Jun 2000 | A |
6090996 | Li | Jul 2000 | A |
6090998 | Grooms et al. | Jul 2000 | A |
6096081 | Grivas et al. | Aug 2000 | A |
6096347 | Geddes et al. | Aug 2000 | A |
6103255 | Levene et al. | Aug 2000 | A |
6110209 | Stone | Aug 2000 | A |
6110482 | Khouri et al. | Aug 2000 | A |
6110746 | Cohen et al. | Aug 2000 | A |
6118043 | Nies et al. | Sep 2000 | A |
6123731 | Boyce et al. | Sep 2000 | A |
6132472 | Bonutti | Oct 2000 | A |
6140087 | Graham et al. | Oct 2000 | A |
6143293 | Weiss et al. | Nov 2000 | A |
6146385 | Torrie et al. | Nov 2000 | A |
6150163 | McPherson et al. | Nov 2000 | A |
6156068 | Walter et al. | Dec 2000 | A |
6156572 | Bellamkonda et al. | Dec 2000 | A |
6159179 | Simonson | Dec 2000 | A |
6165487 | Ashkar et al. | Dec 2000 | A |
6171610 | Vacanti et al. | Jan 2001 | B1 |
6174333 | Kadiyala et al. | Jan 2001 | B1 |
6176880 | Plouhar et al. | Jan 2001 | B1 |
6180605 | Chen et al. | Jan 2001 | B1 |
6183737 | Zaleske et al. | Feb 2001 | B1 |
6189537 | Wolfinbarger, Jr. | Feb 2001 | B1 |
6193647 | Beebe | Feb 2001 | B1 |
6197061 | Masuda et al. | Mar 2001 | B1 |
6197586 | Bhatnagar et al. | Mar 2001 | B1 |
6200347 | Anderson et al. | Mar 2001 | B1 |
6201165 | Grant et al. | Mar 2001 | B1 |
6214368 | Lee et al. | Apr 2001 | B1 |
6221854 | Radomsky | Apr 2001 | B1 |
6231607 | Ben-Bassat et al. | May 2001 | B1 |
6231879 | Li et al. | May 2001 | B1 |
6235316 | Adkisson | May 2001 | B1 |
6242247 | Rieser et al. | Jun 2001 | B1 |
6261143 | Schwartz et al. | Jun 2001 | B1 |
6258778 | Rodgers et al. | Jul 2001 | B1 |
6261586 | McKay | Jul 2001 | B1 |
6267786 | Stone | Jul 2001 | B1 |
6270528 | McKay | Aug 2001 | B1 |
6274090 | Coelho et al. | Aug 2001 | B1 |
6274663 | Hosokawa et al. | Aug 2001 | B1 |
6274712 | Springer et al. | Aug 2001 | B1 |
6280473 | Lemperle et al. | Aug 2001 | B1 |
6281195 | Rueger et al. | Aug 2001 | B1 |
6283980 | Vibe-Hansen et al. | Sep 2001 | B1 |
6288043 | Spiro et al. | Sep 2001 | B1 |
6293970 | Welfinbarger, Jr. et al. | Sep 2001 | B1 |
6294187 | Boyce et al. | Sep 2001 | B1 |
6294202 | Burns et al. | Sep 2001 | B1 |
6294359 | Fiddes et al. | Sep 2001 | B1 |
6303585 | Spire et al. | Oct 2001 | B1 |
6305379 | Wolfinbarger, Jr. | Oct 2001 | B1 |
6306169 | Lee et al. | Oct 2001 | B1 |
6306174 | Gie et al. | Oct 2001 | B1 |
6306424 | Vyakarnam et al. | Oct 2001 | B1 |
6310267 | Rapp | Oct 2001 | B1 |
6312725 | Wallace et al. | Nov 2001 | B1 |
6315992 | Noh et al. | Nov 2001 | B1 |
6319712 | Meenen et al. | Nov 2001 | B1 |
6322583 | Cummings et al. | Nov 2001 | B1 |
6331312 | Lee et al. | Dec 2001 | B1 |
6333029 | Vyakarnam et al. | Dec 2001 | B1 |
6334968 | Shapiro et al. | Jan 2002 | B1 |
6337198 | Levene et al. | Jan 2002 | B1 |
6346515 | Pitaru et al. | Feb 2002 | B1 |
6352558 | Spector | Mar 2002 | B1 |
6352971 | Deisher et al. | Mar 2002 | B1 |
6361565 | Bonutti | Mar 2002 | B1 |
6371958 | Overaker | Apr 2002 | B1 |
6375935 | Constantz | Apr 2002 | B1 |
6376244 | Atala | Apr 2002 | B1 |
6378527 | Hungerford et al. | Apr 2002 | B1 |
6379367 | Vibe-Hansen et al. | Apr 2002 | B1 |
6379385 | Kalas et al. | Apr 2002 | B1 |
6383221 | Scarborough et al. | May 2002 | B1 |
6387693 | Rieser et al. | May 2002 | B2 |
6398811 | McKay | Jun 2002 | B1 |
6398816 | Breitbart et al. | Jun 2002 | B1 |
6398972 | Blasetti et al. | Jun 2002 | B1 |
6406476 | Kirwan, Jr. et al. | Jun 2002 | B1 |
6417247 | Armstrong et al. | Jul 2002 | B1 |
6425918 | Shapiro et al. | Jul 2002 | B1 |
6432436 | Gertzman et al. | Aug 2002 | B1 |
6432713 | Takagi et al. | Aug 2002 | B2 |
6437018 | Gertzman et al. | Aug 2002 | B1 |
6440141 | Phiiippon | Aug 2002 | B1 |
6440427 | Wadstrom | Aug 2002 | B1 |
6440444 | Boyce et al. | Aug 2002 | B2 |
6440934 | Whitehouse | Aug 2002 | B1 |
6443988 | Felt et al. | Sep 2002 | B2 |
6444222 | Asculai et al. | Sep 2002 | B1 |
6447701 | Heschel et al. | Sep 2002 | B1 |
6451060 | Masuda et al. | Sep 2002 | B2 |
6454811 | Sherwood et al. | Sep 2002 | B1 |
6458144 | Morris et al. | Oct 2002 | B1 |
6458158 | Anderson et al. | Oct 2002 | B1 |
6458375 | Gertzman et al. | Oct 2002 | B1 |
6468314 | Schwartz et al. | Oct 2002 | B2 |
6475175 | Rivera et al. | Nov 2002 | B1 |
6486377 | Rapp | Nov 2002 | B2 |
6488033 | Cerundolo | Dec 2002 | B1 |
6489165 | Bhatnagar et al. | Dec 2002 | B2 |
6489455 | Chenchik et al. | Dec 2002 | B2 |
6497726 | Carter et al. | Dec 2002 | B1 |
6503277 | Bonutti | Jan 2003 | B2 |
6504079 | Tucker et al. | Jan 2003 | B2 |
6511511 | Slivka et al. | Jan 2003 | B1 |
6511958 | Atkinson et al. | Jan 2003 | B1 |
6514514 | Atkinson et al. | Feb 2003 | B1 |
6517872 | Yayon et al. | Feb 2003 | B1 |
6520964 | Tallarida et al. | Feb 2003 | B2 |
6528052 | Smith et al. | Mar 2003 | B1 |
6530956 | Mansmann | Mar 2003 | B1 |
6533821 | Lally | Mar 2003 | B1 |
6534084 | Vyakarnam et al. | Mar 2003 | B1 |
6541024 | Kadiyala et al. | Apr 2003 | B1 |
6548729 | Seelich et al. | Apr 2003 | B1 |
6551784 | Fodor et al. | Apr 2003 | B2 |
6569172 | Asculai et al. | May 2003 | B2 |
6576015 | Geistlich et al. | Jun 2003 | B2 |
6576265 | Spievack | Jun 2003 | B1 |
6576285 | Bader et al. | Jun 2003 | B1 |
6579538 | Spievack | Jun 2003 | B1 |
6582960 | Martin et al. | Jun 2003 | B1 |
6591581 | Schmieding | Jul 2003 | B2 |
6592598 | Vibe-Hansen et al. | Jul 2003 | B2 |
6592599 | Vibe-Hansen et al. | Jul 2003 | B2 |
6599300 | Vibe-Hansen et al. | Jul 2003 | B2 |
6599301 | Vibe-Hansen et al. | Jul 2003 | B2 |
6599515 | Delmotte | Jul 2003 | B1 |
6607879 | Cocks et al. | Aug 2003 | B1 |
6623963 | Muller et al. | Sep 2003 | B1 |
6624245 | Wallace et al. | Sep 2003 | B2 |
6626950 | Brown et al. | Sep 2003 | B2 |
6630000 | Bonutti | Oct 2003 | B1 |
6630457 | Aeschlimann et al. | Oct 2003 | B1 |
6632247 | Boyer, II et al. | Oct 2003 | B2 |
6632651 | Neve et al. | Oct 2003 | B1 |
6645727 | Thomas et al. | Nov 2003 | B2 |
6645764 | Adkisson | Nov 2003 | B1 |
6652592 | Grooms et al. | Nov 2003 | B1 |
6652593 | Boyer, II et al. | Nov 2003 | B2 |
6652872 | Neve et al. | Nov 2003 | B2 |
6662805 | Frondoza et al. | Dec 2003 | B2 |
6666892 | Hiles et al. | Dec 2003 | B2 |
6673286 | Shih et al. | Jan 2004 | B2 |
6686184 | Anderson et al. | Feb 2004 | B1 |
6689747 | Filvaroff et al. | Feb 2004 | B2 |
6696073 | Boyce et al. | Feb 2004 | B2 |
6712851 | Lemperle et al. | Mar 2004 | B1 |
6727224 | Zhang et al. | Apr 2004 | B1 |
6730314 | Jeschke et al. | May 2004 | B2 |
6734018 | Wolfinbarger, Jr. et al. | May 2004 | B2 |
6737072 | Angele et al. | May 2004 | B1 |
6743232 | Overaker et al. | Jun 2004 | B2 |
6752834 | Geistlich et al. | Jun 2004 | B2 |
6753311 | Fertala et al. | Jun 2004 | B2 |
6761739 | Shepard | Jul 2004 | B2 |
6761887 | Kavalkovich et al. | Jul 2004 | B1 |
6764517 | Yamamoto et al. | Jul 2004 | B2 |
6767369 | Boyer, II et al. | Jul 2004 | B2 |
6773723 | Spiro et al. | Aug 2004 | B1 |
6776800 | Boyer, II et al. | Aug 2004 | B2 |
6783712 | Slivka et al. | Aug 2004 | B2 |
6790454 | Abdul Malak et al. | Sep 2004 | B1 |
6803234 | Havenga et al. | Oct 2004 | B2 |
6808585 | Boyce et al. | Oct 2004 | B2 |
6808920 | Goshoo | Oct 2004 | B2 |
6815416 | Carney et al. | Nov 2004 | B2 |
6838440 | Stiles | Jan 2005 | B2 |
6841150 | Halvorsen et al. | Jan 2005 | B2 |
6852114 | Cerundolo | Feb 2005 | B2 |
6852125 | Simon et al. | Feb 2005 | B2 |
6852331 | Lai et al. | Feb 2005 | B2 |
6855167 | Shimp et al. | Feb 2005 | B2 |
6855169 | Boyer, II et al. | Feb 2005 | B2 |
6855189 | Ediinger | Feb 2005 | B2 |
6858042 | Nadler et al. | Feb 2005 | B2 |
6866668 | Giannetti et al. | Mar 2005 | B2 |
6875442 | Holy et al. | Apr 2005 | B2 |
6884428 | Binette et al. | Apr 2005 | B2 |
6890354 | Steiner et al. | May 2005 | B2 |
6893462 | Buskirk et al. | May 2005 | B2 |
6893466 | Trieu | May 2005 | B2 |
6896904 | Spiro et al. | May 2005 | B2 |
6902578 | Anderson et al. | Jun 2005 | B1 |
6902584 | Kwan et al. | Jun 2005 | B2 |
6911212 | Gertzman et al. | Jun 2005 | B2 |
6932977 | Heidaran et al. | Aug 2005 | B2 |
6933326 | Griffey et al. | Aug 2005 | B1 |
6939562 | Spiro et al. | Sep 2005 | B2 |
6949252 | Mizuno et al. | Sep 2005 | B2 |
6962814 | Mitchell et al. | Nov 2005 | B2 |
6989034 | Hammer et al. | Jan 2006 | B2 |
6991652 | Burg | Jan 2006 | B2 |
6993328 | Oommen | Jan 2006 | B1 |
6995013 | Connelly et al. | Feb 2006 | B2 |
7009039 | Yayon et al. | Mar 2006 | B2 |
7018416 | Hanson et al. | Mar 2006 | B2 |
7022516 | Kanegasaki | Apr 2006 | B2 |
7025916 | Bachrach | Apr 2006 | B2 |
7033587 | Halvorsen et al. | Apr 2006 | B2 |
7041641 | Rueger et al. | May 2006 | B2 |
7044968 | Yaccarino, III et al. | May 2006 | B1 |
7045141 | Merboth et al. | May 2006 | B2 |
7048750 | Vibe-Hansen et al. | May 2006 | B2 |
7048762 | Sander et al. | May 2006 | B1 |
7048785 | Grooms et al. | May 2006 | B2 |
7067123 | Gomes et al. | Jun 2006 | B2 |
7070942 | Heidaran et al. | Jul 2006 | B2 |
7078232 | Konkle et al. | Jul 2006 | B2 |
7087082 | Paul et al. | Aug 2006 | B2 |
7108721 | Huckle et al. | Sep 2006 | B2 |
RE39321 | MacPhee et al. | Oct 2006 | E |
7115146 | Boyer, II et al. | Oct 2006 | B2 |
7125423 | Hazebrouck | Oct 2006 | B2 |
7125569 | Nur et al. | Oct 2006 | B2 |
7132110 | Kay et al. | Nov 2006 | B2 |
7137989 | Asculai et al. | Nov 2006 | B2 |
7141072 | Geistlich et al. | Nov 2006 | B2 |
7148209 | Hoemann et al. | Dec 2006 | B2 |
7156880 | Evans et al. | Jan 2007 | B2 |
7157428 | Kusanagi et al. | Jan 2007 | B2 |
7163563 | Schwartz et al. | Jan 2007 | B2 |
7166133 | Evans et al. | Jan 2007 | B2 |
7169610 | Brown | Jan 2007 | B2 |
7175852 | Simmoteit et al. | Feb 2007 | B2 |
7179299 | Edwards et al. | Feb 2007 | B2 |
7182781 | Bianchi et al. | Feb 2007 | B1 |
7192604 | Brown et al. | Mar 2007 | B2 |
7201917 | Malaviya et al. | Apr 2007 | B2 |
7208177 | Geistlich et al. | Apr 2007 | B2 |
7217294 | Kusanagi et al. | May 2007 | B2 |
7220558 | Luyten et al. | May 2007 | B2 |
7226482 | Messerli et al. | Jun 2007 | B2 |
7241316 | Evans et al. | Jul 2007 | B2 |
7252987 | Bachalo et al. | Aug 2007 | B2 |
7264634 | Schmieding | Sep 2007 | B2 |
7288406 | Bogin et al. | Oct 2007 | B2 |
7291189 | Hodorek | Nov 2007 | B2 |
7297181 | Fell | Nov 2007 | B2 |
7299805 | Bonutti | Nov 2007 | B2 |
7309232 | Rutherford et al. | Dec 2007 | B2 |
7316822 | Binette et al. | Jan 2008 | B2 |
7323011 | Shepard et al. | Jan 2008 | B2 |
7323445 | Zhang et al. | Jan 2008 | B2 |
7326571 | Freyman | Feb 2008 | B2 |
7335508 | Yayon et al. | Feb 2008 | B2 |
7338492 | Singhatat et al. | Mar 2008 | B2 |
7338524 | Fell et al. | Mar 2008 | B2 |
7358284 | Griffey et al. | Apr 2008 | B2 |
7361195 | Schwartz et al. | Apr 2008 | B2 |
7365051 | Paulista et al. | Apr 2008 | B2 |
7371400 | Barenstein et al. | May 2008 | B2 |
7452677 | Lundgren-.ANG.kerlund | Nov 2008 | B2 |
7468075 | Lang et al. | Dec 2008 | B2 |
7468192 | Mizuno et al. | Dec 2008 | B2 |
7476257 | Sah et al. | Jan 2009 | B2 |
7479160 | Branch et al. | Jan 2009 | B2 |
7485310 | Luyten et al. | Feb 2009 | B2 |
7488348 | Truncale et al. | Feb 2009 | B2 |
7507286 | Edidin et al. | Mar 2009 | B2 |
7513910 | Buskirk et al. | Apr 2009 | B2 |
7524513 | Hai-Quan et al. | Apr 2009 | B2 |
7531000 | Hodorek | May 2009 | B2 |
7531503 | Atala et al. | May 2009 | B2 |
7537617 | Bindsell et al. | May 2009 | B2 |
7537780 | Mizuno et al. | May 2009 | B2 |
7550007 | Malinin | Jun 2009 | B2 |
7560432 | Kusanagi et al. | Jul 2009 | B2 |
7563455 | McKay | Jul 2009 | B2 |
7563769 | Bogin et al. | Jul 2009 | B2 |
7595082 | Pedrozo et al. | Sep 2009 | B2 |
7601173 | Messerli et al. | Oct 2009 | B2 |
7608113 | Boyer, II et al. | Oct 2009 | B2 |
7618646 | Goerne et al. | Nov 2009 | B2 |
7621963 | Simon et al. | Nov 2009 | B2 |
7622438 | Lazarov et al. | Nov 2009 | B1 |
7622562 | Thorne et al. | Nov 2009 | B2 |
7625581 | Laredo et al. | Dec 2009 | B2 |
7628851 | Armitage et al. | Dec 2009 | B2 |
7632311 | Seedhom et al. | Dec 2009 | B2 |
7635592 | West et al. | Dec 2009 | B2 |
7638486 | Lazarov et al. | Dec 2009 | B2 |
7642092 | Maor | Jan 2010 | B2 |
7648700 | Vignery et al. | Jan 2010 | B2 |
7648985 | Vignery et al. | Jan 2010 | B2 |
7658768 | Miller et al. | Feb 2010 | B2 |
7662184 | Edwards et al. | Feb 2010 | B2 |
7666230 | Orban et al. | Feb 2010 | B2 |
7731756 | Maspero et al. | Jun 2010 | B2 |
7763272 | Offermann et al. | Jul 2010 | B2 |
7767806 | Hirakura et al. | Aug 2010 | B2 |
7824701 | Binette et al. | Nov 2010 | B2 |
7837740 | Semler et al. | Nov 2010 | B2 |
7848486 | Shea et al. | Dec 2010 | B2 |
7875296 | Binette et al. | Jan 2011 | B2 |
7892799 | Smith et al. | Feb 2011 | B2 |
RE42208 | Truncale et al. | Mar 2011 | E |
7901457 | Truncale et al. | Mar 2011 | B2 |
7901461 | Harmon et al. | Mar 2011 | B2 |
7931687 | Masuda et al. | Apr 2011 | B2 |
8029992 | Rapko et al. | Oct 2011 | B2 |
8030361 | Aso et al. | Oct 2011 | B2 |
8039258 | Harris et al. | Oct 2011 | B2 |
8043627 | Scharnweber et al. | Oct 2011 | B2 |
8062655 | Johnson et al. | Nov 2011 | B2 |
8105380 | Kharazi et al. | Jan 2012 | B2 |
RE43208 | Yang et al. | Feb 2012 | E |
8110007 | Borden | Feb 2012 | B2 |
8119783 | Bogin et al. | Feb 2012 | B2 |
8147882 | McKay | Apr 2012 | B2 |
8185485 | Keith et al. | May 2012 | B2 |
8292968 | Truncale et al. | Oct 2012 | B2 |
8420858 | Hwang et al. | Apr 2013 | B2 |
8469980 | Sengun et al. | Jun 2013 | B2 |
8507261 | Ogihara et al. | Aug 2013 | B2 |
8685107 | Claesson et al. | Apr 2014 | B2 |
8921109 | Smith et al. | Dec 2014 | B2 |
20010005592 | Bhatnagar et al. | Jun 2001 | A1 |
20010006634 | Zaleske et al. | Jul 2001 | A1 |
20010010023 | Schwartz et al. | Jul 2001 | A1 |
20010011131 | Luyten et al. | Aug 2001 | A1 |
20010011170 | Davison et al. | Aug 2001 | A1 |
20010016646 | Rueger et al. | Aug 2001 | A1 |
20010018619 | Enzerink et al. | Aug 2001 | A1 |
20010020188 | Sander | Sep 2001 | A1 |
20010021529 | Takagi | Sep 2001 | A1 |
20010021875 | Enzerink et al. | Sep 2001 | A1 |
20010031254 | Bianchi et al. | Oct 2001 | A1 |
20010039457 | Boyer et al. | Nov 2001 | A1 |
20010039458 | Boyer et al. | Nov 2001 | A1 |
20010041941 | Boyer et al. | Nov 2001 | A1 |
20010043940 | Boyce et al. | Nov 2001 | A1 |
20010051834 | Frondoza et al. | Dec 2001 | A1 |
20010055615 | Wallace et al. | Dec 2001 | A1 |
20020009805 | Nevo et al. | Jan 2002 | A1 |
20020016592 | Branch et al. | Feb 2002 | A1 |
20020022884 | Mansmann | Feb 2002 | A1 |
20020035401 | Boyce et al. | Mar 2002 | A1 |
20020042373 | Carney et al. | Apr 2002 | A1 |
20020045940 | Giannetti et al. | Apr 2002 | A1 |
20020055783 | Tallarida et al. | May 2002 | A1 |
20020062152 | Dauner et al. | May 2002 | A1 |
20020072806 | Buskirk et al. | Jun 2002 | A1 |
20020082220 | Hoemann et al. | Jun 2002 | A1 |
20020082623 | Osther et al. | Jun 2002 | A1 |
20020082704 | Cerundolo | Jun 2002 | A1 |
20020099448 | Hiles et al. | Jul 2002 | A1 |
20020106393 | Bianchi et al. | Aug 2002 | A1 |
20020106625 | Hung et al. | Aug 2002 | A1 |
20020111695 | Kandel | Aug 2002 | A1 |
20020120274 | Overaker et al. | Aug 2002 | A1 |
20020138143 | Grooms et al. | Sep 2002 | A1 |
20020177224 | Madry et al. | Nov 2002 | A1 |
20020177859 | Monassevitch et al. | Nov 2002 | A1 |
20020192283 | Merboth et al. | Dec 2002 | A1 |
20030021827 | Malaviya et al. | Jan 2003 | A1 |
20030023316 | Brown et al. | Jan 2003 | A1 |
20030032981 | Pelo et al. | Feb 2003 | A1 |
20030033021 | Plouhar et al. | Feb 2003 | A1 |
20030033022 | Plouhar et al. | Feb 2003 | A1 |
20030036797 | Malaviya et al. | Feb 2003 | A1 |
20030036801 | Schwartz et al. | Feb 2003 | A1 |
20030039695 | Geistlich et al. | Feb 2003 | A1 |
20030040113 | Mizuno et al. | Feb 2003 | A1 |
20030044444 | Malaviya et al. | Mar 2003 | A1 |
20030049299 | Malaviya et al. | Mar 2003 | A1 |
20030050709 | Noth et al. | Mar 2003 | A1 |
20030055502 | Lang et al. | Mar 2003 | A1 |
20030078617 | Schwartz et al. | Apr 2003 | A1 |
20030095993 | Bentz et al. | May 2003 | A1 |
20030099620 | Zaleske et al. | May 2003 | A1 |
20030144743 | Edwards et al. | Jul 2003 | A1 |
20030198628 | Hammerman | Oct 2003 | A1 |
20030225355 | Butler | Dec 2003 | A1 |
20030229400 | Masuda et al. | Dec 2003 | A1 |
20030236573 | Evans et al. | Dec 2003 | A1 |
20040028717 | Sittinger et al. | Feb 2004 | A1 |
20040033212 | Thomson et al. | Feb 2004 | A1 |
20040039447 | Simon et al. | Feb 2004 | A1 |
20040044408 | Hungerford et al. | Mar 2004 | A1 |
20040062753 | Rezania et al. | Apr 2004 | A1 |
20040078090 | Binette et al. | Apr 2004 | A1 |
20040082084 | Reisner et al. | Apr 2004 | A1 |
20040102850 | Shepard | May 2004 | A1 |
20040107003 | Boyer et al. | Jun 2004 | A1 |
20040115172 | Bianchi et al. | Jun 2004 | A1 |
20040134502 | Mizuno et al. | Jul 2004 | A1 |
20040138748 | Boyer et al. | Jul 2004 | A1 |
20040143344 | Malaviya et al. | Jul 2004 | A1 |
20040151705 | Mizuno et al. | Aug 2004 | A1 |
20040166169 | Malaviya et al. | Aug 2004 | A1 |
20040170610 | Slavin et al. | Sep 2004 | A1 |
20040175826 | Maor | Sep 2004 | A1 |
20040192605 | Zhang et al. | Sep 2004 | A1 |
20040193154 | Leatherbury et al. | Sep 2004 | A1 |
20040193208 | Hazebrouck | Sep 2004 | A1 |
20040197307 | Rezania et al. | Oct 2004 | A1 |
20040197311 | Brekke et al. | Oct 2004 | A1 |
20040197373 | Gertzman et al. | Oct 2004 | A1 |
20040197375 | Rezania et al. | Oct 2004 | A1 |
20040214313 | Zhang | Oct 2004 | A1 |
20040219182 | Gomes et al. | Nov 2004 | A1 |
20040220574 | Pelo et al. | Nov 2004 | A1 |
20040230303 | Gomes et al. | Nov 2004 | A1 |
20040234549 | Chiang et al. | Nov 2004 | A1 |
20040243242 | Sybert et al. | Dec 2004 | A1 |
20040267277 | Zannis et al. | Dec 2004 | A1 |
20050004672 | Pafford et al. | Jan 2005 | A1 |
20050027307 | Schwartz et al. | Feb 2005 | A1 |
20050038520 | Binette et al. | Feb 2005 | A1 |
20050042254 | Freyman et al. | Feb 2005 | A1 |
20050043814 | Kusanagi et al. | Feb 2005 | A1 |
20050064042 | Vunjak-Novakovic et al. | Mar 2005 | A1 |
20050074476 | Gendler et al. | Apr 2005 | A1 |
20050074481 | Brekke et al. | Apr 2005 | A1 |
20050089544 | Khouri et al. | Apr 2005 | A1 |
20050101957 | Buskirk et al. | May 2005 | A1 |
20050112761 | Halvorsen et al. | May 2005 | A1 |
20050125077 | Harmon et al. | Jun 2005 | A1 |
20050129668 | Giannetti et al. | Jun 2005 | A1 |
20050152882 | Kizer et al. | Jul 2005 | A1 |
20050159820 | Yoshikawa et al. | Jul 2005 | A1 |
20050159822 | Griffey et al. | Jul 2005 | A1 |
20050161857 | Coombes et al. | Jul 2005 | A1 |
20050191248 | Hunter et al. | Sep 2005 | A1 |
20050196480 | Malinin | Sep 2005 | A1 |
20050209705 | Niederauer et al. | Sep 2005 | A1 |
20050222687 | Vunjak-Novakovic et al. | Oct 2005 | A1 |
20050228498 | Andres | Oct 2005 | A1 |
20050240281 | Slivka et al. | Oct 2005 | A1 |
20050251288 | Truncate | Nov 2005 | A1 |
20050255458 | Polansky | Nov 2005 | A1 |
20050260612 | Padmini et al. | Nov 2005 | A1 |
20050261681 | Branch et al. | Nov 2005 | A9 |
20050261767 | Anderson et al. | Nov 2005 | A1 |
20050288796 | Awad et al. | Dec 2005 | A1 |
20060030948 | Manrique et al. | Feb 2006 | A1 |
20060060209 | Shepard | Mar 2006 | A1 |
20060099234 | Winkler | May 2006 | A1 |
20060105015 | Perla et al. | May 2006 | A1 |
20060111778 | Michalow | May 2006 | A1 |
20060141607 | Wikswo | Jun 2006 | A1 |
20060167483 | Asculai et al. | Jul 2006 | A1 |
20060178748 | Dinger et al. | Aug 2006 | A1 |
20060200186 | Hanson et al. | Sep 2006 | A1 |
20060204445 | Atala et al. | Sep 2006 | A1 |
20060210643 | Truncale et al. | Sep 2006 | A1 |
20060216323 | Knaack et al. | Sep 2006 | A1 |
20060216822 | Mizuno et al. | Sep 2006 | A1 |
20060235534 | Gertzman et al. | Oct 2006 | A1 |
20060247790 | McKay | Nov 2006 | A1 |
20060247791 | McKay et al. | Nov 2006 | A1 |
20060251631 | Adkisson et al. | Nov 2006 | A1 |
20060276907 | Boyer et al. | Dec 2006 | A1 |
20060286144 | Yang et al. | Dec 2006 | A1 |
20070009610 | Syring | Jan 2007 | A1 |
20070014867 | Kusanagi et al. | Jan 2007 | A1 |
20070026030 | Gill et al. | Feb 2007 | A1 |
20070036834 | Pauletti et al. | Feb 2007 | A1 |
20070041950 | Leatherbury et al. | Feb 2007 | A1 |
20070043376 | Leatherbury et al. | Feb 2007 | A1 |
20070055377 | Hanson et al. | Mar 2007 | A1 |
20070057175 | Mordehai et al. | Mar 2007 | A1 |
20070065943 | Smith et al. | Mar 2007 | A1 |
20070067032 | Felt et al. | Mar 2007 | A1 |
20070083266 | Lang | Apr 2007 | A1 |
20070093896 | Malinin | Apr 2007 | A1 |
20070093912 | Borden | Apr 2007 | A1 |
20070098759 | Malinin | May 2007 | A1 |
20070100450 | Hodorek | May 2007 | A1 |
20070113951 | Huang | May 2007 | A1 |
20070128155 | Seyedin et al. | Jun 2007 | A1 |
20070134291 | Ting et al. | Jun 2007 | A1 |
20070135917 | Malinin | Jun 2007 | A1 |
20070135918 | Malinin | Jun 2007 | A1 |
20070135928 | Malinin | Jun 2007 | A1 |
20070148242 | Vilei et al. | Jun 2007 | A1 |
20070162121 | Tarrant et al. | Jul 2007 | A1 |
20070168030 | Edwards et al. | Jul 2007 | A1 |
20070172506 | Nycz et al. | Jul 2007 | A1 |
20070178159 | Chen et al. | Aug 2007 | A1 |
20070179607 | Hodorek et al. | Aug 2007 | A1 |
20070185585 | Bracy et al. | Aug 2007 | A1 |
20070190030 | Pawliuk et al. | Aug 2007 | A1 |
20070202190 | Borden | Aug 2007 | A1 |
20070219497 | Johnson et al. | Sep 2007 | A1 |
20070276506 | Troxel | Nov 2007 | A1 |
20070299517 | Davisson et al. | Dec 2007 | A1 |
20070299519 | Schmieding | Dec 2007 | A1 |
20080015709 | Evans et al. | Jan 2008 | A1 |
20080027546 | Semler et al. | Jan 2008 | A1 |
20080031915 | Becerra Ratia et al. | Feb 2008 | A1 |
20080038314 | Hunziker | Feb 2008 | A1 |
20080039939 | Iwamoto et al. | Feb 2008 | A1 |
20080039954 | Long | Feb 2008 | A1 |
20080039955 | Hunziker | Feb 2008 | A1 |
20080051889 | Hodorek | Feb 2008 | A1 |
20080055210 | McKay | Mar 2008 | A1 |
20080064090 | Whittlinger | Mar 2008 | A1 |
20080077251 | Chen et al. | Mar 2008 | A1 |
20080119947 | Huckle et al. | May 2008 | A1 |
20080125883 | McKay | May 2008 | A1 |
20080125888 | Branemark et al. | May 2008 | A1 |
20080133008 | Truncale et al. | Jun 2008 | A1 |
20080138414 | Huckle et al. | Jun 2008 | A1 |
20080153157 | Yao et al. | Jun 2008 | A1 |
20080154372 | Peckham | Jun 2008 | A1 |
20080166329 | Sung et al. | Jul 2008 | A1 |
20080167716 | Schwartz et al. | Jul 2008 | A1 |
20080183300 | Seedhom et al. | Jul 2008 | A1 |
20080220044 | Semler et al. | Sep 2008 | A1 |
20080255676 | Semler et al. | Oct 2008 | A1 |
20080260801 | Ahlers et al. | Oct 2008 | A1 |
20080274157 | Vunjak-Novakovic et al. | Nov 2008 | A1 |
20080287342 | Yu et al. | Nov 2008 | A1 |
20080305145 | Shelby et al. | Dec 2008 | A1 |
20080306408 | Lo | Dec 2008 | A1 |
20090001267 | Enyama et al. | Jan 2009 | A1 |
20090043389 | Vunjak-Novakovic et al. | Feb 2009 | A1 |
20090069901 | Truncale et al. | Mar 2009 | A1 |
20090069904 | Picha | Mar 2009 | A1 |
20090076624 | Rahaman et al. | Mar 2009 | A1 |
20090099661 | Bhattacharya et al. | Apr 2009 | A1 |
20090112119 | Kim | Apr 2009 | A1 |
20090117652 | Luyten et al. | May 2009 | A1 |
20090131986 | Lee et al. | May 2009 | A1 |
20090139045 | Cannon et al. | Jun 2009 | A1 |
20090143867 | Gage et al. | Jun 2009 | A1 |
20090148941 | Florez et al. | Jun 2009 | A1 |
20090149893 | Semler et al. | Jun 2009 | A1 |
20090210057 | Liao et al. | Aug 2009 | A1 |
20090226523 | Behnam et al. | Sep 2009 | A1 |
20090280179 | Neumann et al. | Nov 2009 | A1 |
20090291112 | Truncale et al. | Nov 2009 | A1 |
20090299475 | Yamamoto et al. | Dec 2009 | A1 |
20090312805 | Lang et al. | Dec 2009 | A1 |
20090312842 | Bursac et al. | Dec 2009 | A1 |
20090319051 | Nycz et al. | Dec 2009 | A9 |
20100015202 | Semler et al. | Jan 2010 | A1 |
20100021521 | Xu et al. | Jan 2010 | A1 |
20100036492 | Hung et al. | Feb 2010 | A1 |
20100036503 | Chen et al. | Feb 2010 | A1 |
20100241228 | Syring et al. | Sep 2010 | A1 |
20100274362 | Yayon et al. | Oct 2010 | A1 |
20100291181 | Uhrich et al. | Nov 2010 | A1 |
20110053841 | Yayon et al. | Mar 2011 | A1 |
20110070271 | Truncale et al. | Mar 2011 | A1 |
20110196508 | Truncale et al. | Aug 2011 | A1 |
20110224797 | Semler et al. | Sep 2011 | A1 |
20110282372 | Schowalter et al. | Nov 2011 | A1 |
20130273121 | Mizuno et al. | Oct 2013 | A1 |
Number | Date | Country |
---|---|---|
0068149 | Jan 1983 | EP |
0075444 | Mar 1983 | EP |
0337677 | Oct 1989 | EP |
0517030 | Dec 1992 | EP |
0522569 | Jan 1993 | EP |
0608546 | Aug 1994 | EP |
0620274 | Oct 1994 | EP |
0674908 | Oct 1995 | EP |
0677297 | Oct 1995 | EP |
0739631 | Oct 1996 | EP |
0784985 | Jul 1997 | EP |
1127581 | Aug 2001 | EP |
1181908 | Feb 2002 | EP |
1208850 | May 2002 | EP |
1234552 | Aug 2002 | EP |
1234555 | Aug 2002 | EP |
1264607 | Dec 2002 | EP |
1384452 | Jan 2004 | EP |
1452191 | Sep 2004 | EP |
1537883 | Jun 2005 | EP |
1561481 | Aug 2005 | EP |
1625832 | Feb 2006 | EP |
1719463 | Nov 2006 | EP |
1719531 | Nov 2006 | EP |
1719532 | Nov 2006 | EP |
1923457 | May 2008 | EP |
2657352 | Jul 1991 | FR |
2102811 | Feb 1983 | GB |
622744 | Feb 1994 | JP |
9001342 | Feb 1990 | WO |
9011354 | Oct 1990 | WO |
9101140 | Feb 1991 | WO |
9109126 | Jun 1991 | WO |
9304169 | Mar 1993 | WO |
9316739 | Sep 1993 | WO |
9320218 | Oct 1993 | WO |
9403584 | Feb 1994 | WO |
9429442 | Dec 1994 | WO |
9525748 | Sep 1995 | WO |
9533502 | Dec 1995 | WO |
9601313 | Jan 1996 | WO |
9603159 | Feb 1996 | WO |
9615818 | May 1996 | WO |
9624310 | Aug 1996 | WO |
9640892 | Dec 1996 | WO |
9707668 | Mar 1997 | WO |
9707669 | Mar 1997 | WO |
9729715 | Aug 1997 | WO |
9740163 | Oct 1997 | WO |
9814222 | Apr 1998 | WO |
9841246 | Sep 1998 | WO |
9843686 | Oct 1998 | WO |
9844874 | Oct 1998 | WO |
9909914 | Mar 1999 | WO |
9911298 | Mar 1999 | WO |
9915209 | Apr 1999 | WO |
9921497 | May 1999 | WO |
9922747 | May 1999 | WO |
9948541 | Sep 1999 | WO |
9952572 | Oct 1999 | WO |
9956797 | Nov 1999 | WO |
00040177 | Jul 2000 | WO |
0044808 | Aug 2000 | WO |
00047114 | Aug 2000 | WO |
0047214 | Aug 2000 | WO |
0102030 | Jan 2001 | WO |
0107595 | Feb 2001 | WO |
0138357 | May 2001 | WO |
0139788 | Jun 2001 | WO |
0143667 | Jun 2001 | WO |
0146418 | Jun 2001 | WO |
02018546 | Mar 2002 | WO |
0222779 | Mar 2002 | WO |
0236732 | May 2002 | WO |
0241877 | May 2002 | WO |
02058484 | Aug 2002 | WO |
02064180 | Aug 2002 | WO |
02077199 | Oct 2002 | WO |
02095019 | Nov 2002 | WO |
03007805 | Jan 2003 | WO |
03007873 | Jan 2003 | WO |
03007879 | Jan 2003 | WO |
03012053 | Feb 2003 | WO |
03035851 | May 2003 | WO |
03040113 | May 2003 | WO |
03049626 | Jun 2003 | WO |
03079885 | Oct 2003 | WO |
03087160 | Oct 2003 | WO |
03094835 | Nov 2003 | WO |
2004016276 | Feb 2004 | WO |
2004060404 | Jul 2004 | WO |
2004067704 | Aug 2004 | WO |
2004069298 | Aug 2004 | WO |
2004075940 | Sep 2004 | WO |
2004096983 | Nov 2004 | WO |
2004103224 | Dec 2004 | WO |
2005023321 | Mar 2005 | WO |
2005023906 | Mar 2005 | WO |
2005058207 | Jun 2005 | WO |
2005110278 | Nov 2005 | WO |
2006001046 | Jan 2006 | WO |
2006038287 | Apr 2006 | WO |
2006042311 | Apr 2006 | WO |
2006050213 | May 2006 | WO |
2006113586 | Oct 2006 | WO |
2007024238 | Mar 2007 | WO |
2007035778 | Mar 2007 | WO |
2007057175 | May 2007 | WO |
2008013763 | Jan 2008 | WO |
2008021127 | Feb 2008 | WO |
2008038287 | Apr 2008 | WO |
2008081463 | Jul 2008 | WO |
2008106254 | Sep 2008 | WO |
2009076164 | Jun 2009 | WO |
2009111069 | Sep 2009 | WO |
2010083051 | Jul 2010 | WO |
2013043072 | Mar 2013 | WO |
Entry |
---|
European Search Opinion and Extended European Search Report in Application No. 15865074.7, dated Jun. 22, 2018. |
OsteoSponge product information, Bacterin International Inc, May 2005. |
Skolnick, J. et al., “From genes to protein structure and function: novel application of computational approaches in the genomic era” Trends BioTechnol., 2000, 18(1):34-39. |
Doerks, T. et al., “Protein annotation: detectivework for protein prediction” Trends Genet., 1998, 14(6): 248-250. |
Cook, J.L. et al., “Biocompatibility of three-dimensional chondrocyte grafts in large tibial defects of rabbits”, Am J. Vet. Res., 2003, 64(1):12-20. |
International Search Report and Written Opinion of the International Searching Authority dated Mar. 14, 2016 for International Application No. PCT/US2015/063161 (17 Pages). |
Office Action dated Apr. 19, 2007 in connection with U.S. Appl. No. 11/151,270. |
Office Action dated Aug. 19, 2009 In connection with U.S. Appl. No. 12/147,042. |
Office Action dated Dec. 18, 2007 In connection with U.S. Appl. No. 11/081,103. |
Office Action dated Feb. 20, 2007 tn connection with U.S. Appl. No. 10/960,960. |
Office Action dated Feb. 6, 2007 in connection with U.S. Appl. No. 10/438,883. |
Office Action dated Feb. 7, 2008 in connection with U.S. Appl. No. 10/815,778. |
Office Action dated Jan. 14, 2010 in connection with U.S. Appl. No. 11/081,103. |
Office Action dated Jul. 2, 2009 in connection with U.S. Appl. No. 10/815,778. |
Office Action dated Jul. 22, 2009 in connection with U.S. Appl. No. 12/010,984. |
Office Action dated Jul. 9, 2008 in connection with U.S. Appl. No. 11/151,270. |
Office Action dated Jun. 3, 2009 in connection with U.S. Appl. No. 11/081,103. |
Office Action dated Jun. 8, 2009 in connection with U.S. Appl. No. 11/481,955. |
Office Action dated May 18, 2009 in connection with U.S. Appl. No. 11/657,042. |
Office Action dated May 3, 2005 in connection with U.S. Appl. No. 10/438,883. |
Office Action dated Nov. 12, 2008 in connection with U.S. Appl. No. 10/438,883. |
Office Action dated Nov. 5, 2004 in connection with U.S. Appl. No. 10/438,883. |
Office Action dated Oct. 5, 2005 in connection with U.S. Appl. No. 10/424,765. |
Corpet, 1988, Multiple sequence alignment with hierarchical clustering, Nucleic Acids Res, 16(22):10881-90. |
Coughlin et al., 1988, Acidic and Basic Fibroblast Growth Factors Stimulate Tyrosine Kinase Activity in Vivo, Journal of Biological Chemistry, 263(2):986-993. |
Coulson et al., 1999, Collagen and a thermally reversible poloxamer deliver demineralized bone matrix (DBM) and biologically active proteins to sites of bone regeneration in: Portland Sons Symposium, Jeffrey O Hollinger: Proceedings from Portland Bone Symposium, Oregon Health Sciences University, US, 619-637. |
Crameri et al., 1997, Molecular evolution of an arsenate detoxification pathway by DNA shuffling. Nature Biotech, 15:436-438. |
Cuenco et, al., 2001, Cooperation of BCR-ABL and AML1/MDSU/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia, Oncogene, 20:8238-8248. |
Dahlberg et, al., 1991, Demineralized Allogeneic Bone Matrix for Cartilage Repair, Journal of Orthopaedic Research, 9:11-19. |
Danilenko et al., 1999, Recombinant rat fibroblast growth factor-16: structure and biological activity, Arch. Biochem. Blophys, 361:34-46. |
De Jagereta et al., 2003, Simultaneous detection of 15 human cytokines in a singie sample of stimulated peripheral blood mononuclear cells, Clin & Diagn Lab Immunol, 10:133-139. |
DeKoter et. al., 1998, EMBO 17:4456-4468. |
Delezoide et. al., 1998, Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification, Mech Dev 77(1):19-30. |
Dell'Accio et. al., 2001, Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo, Arthritis Rheum, 44(7):1608-19. |
Dellow, et. al., 2001, Cardiovasc Res 50:3-6. |
Deng et. al., 1996, Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth, Cell 84:911-921. |
Denissen et. al., 1994, Bone Miner, 25:123-134. |
Denissen, et. al., 2009, J Periodontol, 71:279-86. |
Diduch et. al., 2002, Joint Repair: Treatment Options far Articular Cartilage Injury Orthopedic Technology Review, 4:24-27. |
Dinser et. al., 2001, Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articuiar chondrocytes, Histochem Cell Biol, 116(1):69-77. |
Dionne et. al., 1990, Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors, The EMBO Joumal, 9(9):2685-2692. |
Dreyfus et. al., 1995, Expression of the Evi-1 gene in myelodysplastic syndromes, Leukemia, 9:203-205. |
Dvorakova et. al., 2001, Changes In The Expression Of FGFR3 In Patients With Chronic Myeloid Leukaemia Receiving Transplants Of Allogeneic Peripheral Blood Stem Cells, British Journal of Haematology, 113:832-835. |
Eliopoulos et. al., 2002, Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells, Gene Ther, 9:452-462. |
Elroy-Stein et. al., 1989, Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacterophage T7 hybrid expression system, Proc. Natl. Acad. Sci., 86:6126-6130. |
EP App No. 2004/0781499, Third party observation, mailed Jul. 30, 2014. |
Eriksson et. al., 1991, Three-Dimensional structure of human basic fibroblast growth factor Proceedings of the National Academy of Science of USA, National Academy of Science, Washington, DC, US, 88:3441-3445. |
Eriebacher et. al., 1995, Toward a Molecular Understanding of Skeletal Development, Cell, 80:371-378. |
European Search Report and Opinion for EP1119081.17 dated Feb. 14, 2012, 10 pages. |
Evans et. al., 2004, Osteoarthritis gene therapy Gene Ther, 11(4):379-89. |
Extended European Search Report for European Patent Application No. 06814983.0, dated Apr. 19, 2012, 7 pages. |
Ezzat et. al., 2002, Targeted Expression of a Human Pituitary Tumor-Derived Isoform of FGF Receptor-4 Recapitulates Pituitary Tumorigenesis, The Journal of Clinical Investigation, 109:69-78. |
F Lincoln Avery, Anterior Cruciate Ligament (ACL) Graft Options, hitp://wwworthoassociatescom/ACL_graftshtm, Internet Article, The Sports Medicine Center, 1-15, Downloaded Jan. 9, 2007. |
Feham et. al., 1998, Diversity Does Make a Difference: Fibroblast Growth Factor-Heparin Interactions, Current Opinion in Structural Biology, 8:578-586. |
Feller et. al., 1984, Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines, J Virol, 49(1):269-272. |
Zhang et. al., 2004, Hyaline cartilage engineered by chondrocytes in pellet culture, histological., immunohistochemical and ultrastructural analysis in comparison with cartilage explants, J. Anat., 205(3):229-37. |
Zhu et. al., 1995, GLU-96 of Basic Fibroblast Growth Factor Is Essential for High Affinity Receptor Binding Journal of Biological Chemistry, American, Society of Biochemical Biologists, Birmingham US, 270(37):21869-21874. |
Zhu et. al., 1997, Analysis of high-affinity binding determinants in the receptor binding epitope of basic fibroblast growth factor, Protein Engineering, 10:417-421. |
Messner et. al., 1996, The Long-term Prognosis for Severe Damage to Weight-bearing Cartilage in the Knee: A 14-year Clinical and Radiographic Follow-up in 28 Young Athletes, Acta Orthopaedica Scandinavica, 67(2):165-168. |
Mitani et. al., 1994, Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia, EMBO J., 13(3):504-510. |
Miyamoto et al., 1993, Molecular Cloning of Novel Cytokine cDNA Encoding the Ninth Member of the Fibroblast Growth Factor Family, Which Has a Unique Secretion Property, Molecular and Cellular Biology, 13:4251-4259. |
Miyazaki, 2002, Random DNA fragmentation with endonuclease V: application to DNA shuffling, Nucleic Acids Research, 30(24):E139. |
Mohammadi et. al., 2005, Structural Basis for Fibroblast Growth Factor Receptor Activation, Cytokine & Growth Factor Rev., 16:107-137. |
Morishita et. al., 1992, Activation of the EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome 3q26, Proc. Natl. Acad. Sci. USA, 89:3937-3941. |
Morishita et. al., 1992, Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor, Mol Cell Biol., 12:183-189. |
Mucenski et. al., 1988, Identification of a Common Ecotropic Viral Integration Site, Evi-1, iii the DNA of AKXD Murine Myeloid Tumors, Molecular and Cellular Biology, 8:301-308. |
Nakatake et. al., 2001, Identification of a Novel Fibroblast Growth Factor, FGF-22, Preferentially Expressed in the Inner Root Sheath of the Hair Follicle, Biochimica et. Biophysics Acta, 1517:460-463. |
Naruo et. al., 1993, Novel Secretory Heparin-binding Factors from Human Glioma Cells (Glia-activating Factors) Involved in Glial Cell Growth, The Journal of Biological Chemistry, 268(4):2857-2884. |
Needleman et. al., 1970, A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins, J. Mol. Biol., 48:443-453. |
Nehrer et. al., 1998, Chondrocyte-seeded Collagen Matrices Implanted in a Chondral Defect in a Canine Model, Biomaterials, 19:2313-2328. |
Nettles et. al., 2004, in Situ Crosslinkable Hyaluranan for Articular Cartilage Repair, 50th Annual Meeting of the Orthopaedic Research Society, Paper No. 0202. |
Nettles et. al., 2004, Photocrosslinkable Hyaluronan as a Scaffold for Articular Cartilage Repair, Annals of Biomedical Engineering, 32(3):391-397. |
Neville-Webbe et al., 2002, The anti-tumour activity of bisphosphonates, Cancer Treatement Reviews 28(6):305-319. |
Newman, 1998. Articular Cartilage Repair, American Journal of Sports Medicine, 26(2):309-324. |
Ngo et. al., 1994, Computational complexity, protein structure prediction, and the Levirithal Paradox, In: The Protein Folding Problem and Tertiary Structure Prediction K Merz Jr and S Le Grand, Editors:433-506. |
Nishimura et. al., 2000, Identification of a Novel FGF, FGF-21, Preferentially Expressed in the Liver, Biochimica et. Biophysica Acta, 1492:203-206. |
Nixon et. al., 1999, Enhanced Repair of Extensive Articular Defects by Insulin-like Growth Factor-I-Laden Fibrin Composites, Journal of Orthopaedic Research, 17(4):475-487. |
Non-final Office Action for U.S. Appl. No. 12/043,001, dated May 11, 2011. |
Non-final Offce Action with regard to U.S. Appl. No. 12/381,072, dated Jan. 20, 2011. |
O'Gorman et. al., 1991, Recombinase-mediated gene activation and site-specific integration in mammalian cells, Science, 251:1351-1355. |
Obradovic et. al., 2001, Integration of Engineered Cartilage, Journal of Orthopaedic Research, 19:1089-1097. |
Ochi et. al., 2001, Current Concepts in Tissue Engineering Technique for Repair of Cartilage Defect, Artificial Organs, 25(3):172-179. |
Office Action for Canadian Patent Application No. 2,623,106, dated Jul. 10, 2012, 3 pages. |
Office Action for Canadian Patent Application No. 2,623,106, dated Oct. 6, 2011, 4 pages. |
Oh et. al., 2003, Signaling Mechanisms Leading to the Regulation of Differentiation and Apoptosis of Articular Chondrocytes by Insulin-like Growth Factor-1, Journal of Biological Chemistry, 278(38):36563-36571. |
Okada-Ban et. al., 2000, Molecules in focus, Fibroblast Growth Factor-2, The International Journal of Biochemistry & Cell Biology, 32:263-267. |
Olsen et. al., 2003, Fibroblast Growth Factor (FGF) Homologous Factors Share Structural but not Functional Homology with FGFs, J. Biol. Chem., 278(38):34226-34236. |
Olsen et. al., 2004, Insights into the Molecular Basis for Fibroblast Growth Factor Receptor Autoinhibition and Ligand- Binding Promiscuity, Proc. Nati. Acad. Sci., 101:935-940. |
Ornitz et. al., 1992, Ligand Specificity and Heparin Dependence of Fibroblast Growth Factor Receptors 1 and 3, The Journal of Biological Chemistry, 267(23):16305-16311. |
Ornitz et. al., 1996, Receptor Specificity of the Fibroblast Growth Factor Family*, The Journal of Biological Chemistry, 271(25):15292-15297. |
Ornitz et. al., 2001, Protein Family Review, Fibroblast Growth Factors Genome Biology, 2(3):30051-300512. |
Ornitz, 2000, FGFs, heparan sulfate and FGFRs: complex interactions essential for development, Bioessays, 22(2):108-112. |
Patent Examination Report No. 1 for Australian Patent Application No. 2006292224, dated Oct. 4, 2011, 3 pages. |
Patent Examination Report No. 2 for Australian Patent Application No. 2006292224, dated Jul. 3, 2013, 4 pages. |
Pearson et. al., 1988, Improved tools for biological sequence comparison, Proc. Natl. Acad. Sci. USA, 85(8):2444-2448. |
Pei et. al., 2002, Bioreactors Mediate the Effectiveness of Tissue Engineering Scaffolds, The FASEB Journal., 16:1691-1694. |
Pei et. al., 2002, Growth Factors for Sequential Cellular De- and Re-differentiation in Tissue Engineering, Biochemical and Biophysical Research Communications, 294:149-154. |
Pellegrini et. al., 2000, Crystal Structure of Fibroblast Growth Factor Receptor Ectodomain Bound to Ligand and Heparin, Nature, 407:1029-1034. |
Pereboeva et. al., 2003, Approaches to Utilize Mesenchymal Progenitor Cells as Cellular Vehicles, Stem Cells, 21:389-404. |
Peretti et. al., 1998, Bonding of Cartilage Matrices with Cultured Chondrocytes: An Experiential Model, Journal of Orthopedic Research, 16(1):89-95. |
Peretti et. al., 1999, Biomechanical Analysis of a Chondrocyte-Based Repair Model of Articular Cartilage, Tissue Engineering, 5(4):317-326. |
Peretti et. al., 20130, Cell-based Tissue-Engineered Allogeneic Implant for Cartilage Repair, Tissue Engineering, 6(5):567-576. |
Peretti et. al., 2001, A Biomedical Analysis of an Engineered Cell-Scaffold Implant for Cartilage Repair, Annals of Plastic Surgery, 46(5):533-537. |
Peretti et. al., 2003, Cell-Based Bonding of Articular Cartilage: An Extended Study, Journal of Biomedical Materials Research, 64A:517-524. |
Peretti et. al., 2007, In Vitro Bonding of Pre-seeded Chondrocyte, Sport Sciences for Health 2(1):29-33. |
Peterson et. al., 2000, Two- to 9-year Outcome After Autologous Chondrocyte Transplantation of the Knee, Clinical Orthopaedics and Related Research, 374:212-234. |
Peterson et. al., 2002, Autologous Chondrocyte Transplantation: Biomechanics and Long-term Durability, American Journal of Sports Medicine, 30(1):2-12. |
Phillips, 2001, The challenge of gene therapy and DNA delivery, Journal of Pharmacy and Pharmacology, 53:1169/1174. |
Piliai et. al., 2001, Polymers In Drug Delivery, Current Opinion Chemical Biology, 5:447-451. |
Plotnikov et. al., 1999, Structural Basis for FGF Receptor Dimerization and Activation, Cell, 98:641-650. |
Plotnikov et. al., 2000, Crystal Structures of Two FGF-FGFR Complexes Reveal the Deteminants of Ligand-Receptor Specificity, Cell 101:413-424. |
Pollik et. al., 1995; J Oral Maxillofac Surg, 53(8):915-22. |
Pouyani et. al., 1994, Functionalized Derivatives of Hyaluronic Acid Oligosaccharides: Drug Carriers and Novel Biomaterials, Bioconjugate Chem., 5:339-347. |
Presta et. al., 1993, Subcellular Localization and Biological Activity of Mr 18,000 Basic Fibroblast Growth Factor: Site-Directed Mutagenesis of a Putative Nuclear Translocation Sequence, Growth Factors, 9:269-278. |
Prestwich et. al., 1998, Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives, Journal of Controlled Release, 53:93-103. |
Rabie et. al., 1996, Ultrastructural identification ofcells involved in the healing of intramembranous and endochondral bones, Int J Oral Maxillofac Surg, 25(5):383-388. |
Raisz, 1999, Physiology and Pathophysiology of Bone Remodeling, Clinical Chemistry, 45(8):1353-1358. |
Richardson et. al., 1999, Repair of human articular cartilage after implantation of autologous chondrocytes, Journal of Bone and Joint Surgery [Br], 81-B:1064-1068. |
Riggs et. al., 1987, Luciferase reporter gene cassettes for plant gene xpression studies, Nucleic Acid Res 15(19):8115. |
Sahni et. al., 1999, FGF signalin inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway Genes Dev., 13(11):1361-1386. |
Santos-Ocampo et. al., 1996, Expression and Biological Activity of Mouse Fibroblast Growth Factor-9:, The Journal of Biological Chemistry, 271:1726-1731. |
Schaefer et. al., 2002, Tissue Engineered Composites for the Repair of Large Osteochondral Defects, Arthritis & Rheumatism, 46(9):2524-2534. |
Schlessinger et. al., 2000, Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a Dual Role for Heparin in FGFR Binding and Dimerization, Molecular Cell, 6:743-750. |
Schmal et. al., 2007, bFGF influences human articular chondrocyte differentiation, Cytotherapy, 9(2):184-193. |
Schwartz et. al., 1991, A dominant positive and negative selectable gene for use mammalian cells, Proc. Natl. Acad. Sci. USA, 88(23):10416-20. |
Schwarz et. al., 2000, Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis, J Orthop Res, 18:849-55. |
Schwindt et. al., 2009, Effects of FGF-2 and EGF removal on the differentiation of mouse neural precursor cells, An Acad Bras Cienc, 81(3):443-452. |
Search Report Application No. PCT/IL2004/000088 dated Aug. 18, 2004. |
Search Report conducted by the Australian Patent Office dated Mar. 14, 2008 regarding Singapore Patent Application No. 200607828-1. |
Search Report conducted by the Danish Patent Office dated Jul. 15, 2005 regarding Singapore Patent Application No. 200406581-9. |
Search Report for PCT/IL2007/001199, dated Sep. 16, 2008. |
Search Report for PCT/US2008/073762 dated Dec. 22, 2008. |
Search Report, PCT/IL07/01199, dated Sep. 16, 2008. |
Seddon et. al., 1995, Engineering of Fibroblast Growth Factor Alteration of Receptor Binding Specificity, Biochemistry, 34:741-736. |
Shaklee et. al., 1984, Hydrazinolysis of heparin and other glycosaminoglycans, Biochem. J., 217:187-197. |
Sheo et. al., 2006, Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model, Circ J, 70(4):471-477. |
Shibata et. al., 2001, GM-CSF Regulates Alveolar Macrophage Differentiation and Innate Immunity in the Lung through PU.1, Immunity, 15(4):557-567. |
Shu et. al, 2003, Attachment and spreading fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel, Wiley periodicals. |
Shu et. al., 2004, Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel, J Biomed, Mater Res 68A:365-375. |
Sims et. al., 1998, Tissue Engineered Neocartilage Using Plasma Derived Polymer Substrates and Chondrocytes, Plastic & Recon Surg 101(6):1580-1585. |
Skolnick et. al., 2000, From genes to protein structure and function: novel applications of computationai approaches in the genomic era, Trends BioTechnol, 18(1):34-39. |
Sleeman et. al., 2001, Identification of a new fibrobiast growth factor receptor, FGFR5, Gene, 271(2): 171-182. |
Smith et, al., 1996, In vitro stimulation of articular chondrocyte mRNA and extracellular matrix synthesis by hydrostatic pressure, Journal of Orthopaedic Research, John Wiley & Sons, Inc, 14(1):53-60. |
Smith et. al., 1997, The challenges of genome sequence annotation or 'The devilis in the details, Nature Biotechnology, 15(12):1222-1223. |
Soltes et al., 2003, Molecular characterization of two host-guest associating hyaluronan derivatives, Biomedical Chromatography, 17;376-384. |
Song et. al., 2002, Construction of DNA-Shuffled and Incrementally Truncated Libraries by a Mutagenic and Unidirectional Reassembly Method: Changing from a Substrate Specificity of Phospholipase to That of Lipase, Appl. Environ. Microbiol., 68(12):6146-6151. |
Spangenberg et. al., 2002, Histomorphometric Analysis of a Cell-Based Model of Cartilage Repair, Tissue Engineering, 8(5):839-46. |
Springer et. al, 1994, Identification and Concerted Function of Two Receptor:Binding Surfaces on Basic Fibroblast Growth Factor Required for Mitogenesis, The Journal of Biological Chemistry, 269(43):26879-26884. |
Stauber et. al., 2000, Structural interactions of fibroblast growth factor receptor with its ligands, PNAS, 97(1):49-54. |
Stemmer et. al., 1994, DNA shuffling by random fragmentation and reassembly; in vitro recombination for molecular evolution, Proc. Natl. Acad. Sci, USA, 91(22):10747-10751. |
Stone et. al., 2006, Articular Cartilage Paste Grafting to Full-Thickness Articular Cartilage Knee Joint Lesions: A 2- 12-Year Follow-up, Arthroscopy: The Journal of Arthroscopic and Related Surgery, 22(3):291-299. |
Stone et. al., One-Step American Technique of Articular Cartilage Paste Grafting to Traumatic and Arthritic Defects in the Knee Joint (2-7 Years Follow-Up), downloaded from http:webarchive.Org/web/20041205005845/http://www.stoneclinic.com/onestepthm:published Dec. 5, 2004. |
Sun et. al., 2001, Quantitative imaging of gene induction in living animals, Gene Therapy, 8:1572-1579. |
Supplementary European Search Report for EP 03720833, with date of completed search as Apr. 11, 2008. |
Supplementary European Search Report for EP 04706268, with date of completed search as Jan. 12, 2011. |
Supplementary European Search Report for EP 05728956.3, with date of completed search as May 2, 2011. |
Supplementary European Search Report for EP 07827173, with date of completed search as Oct. 30, 2009. |
Supplementary European Search Report for EP02753826 dated Jul. 17, 2009, 2 pages. |
Supplementary European Search Report for EP08768602 dated Oct. 22, 2012, 6 pages. |
Supplementary European Search Report for EP087983003.3 dated Oct. 18, 2012, 6 pages. |
Taylor et. el., 2002, In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study, Int J Oral Maxillofac Implants, 17(3):321-30. |
Thomson et. al., 1995, Fabrication of Biodegradable Polymer Scaffolds to Engineer Trabecular Bones, J Biomater Sci Polymer Edn, 7(1) :23-38. |
Thuerauf et. al., 1997, Differential Effects of Protein Kinase C, Ras, and Raf-1 Kinase on the Induction of the Cardiac B-type Natriuretic Peptide Gene through a Critical Promoter-proximal M-CAT Element, J Biol Chem., 272:7464-7472. |
Tokuriki et. al., 2009, Stability effects of mutations and protein evolvability, Current Opinion in Structural Biology, 19:596-604. |
Tozer et. al., 2005, Tendon and ligament: Development, repair and disease, Birth Defects Research Part C, 75(3):226-236. |
Tsumaki et. al., 1999, Role of CDMP-1 in Skeletal Morphogenesis: Promotion Mesenchymal Cell Recruitment and Chondrocyte Differentiation, J Cell Biol., 144(1):161-173. |
Ui-Tei et, al., 2004, Guidelines forthe selection highly effective siRNA sequences for mammlian and chick RNA interference, NAR 32(3):936-48. |
U.S. Appl. No. 10/982,514, filed Nov. 5, 2004. |
U.S. Appl. No. 10/982,514, Advisory Action dated Jun. 26, 2008. |
U.S. Appl. No. 10/982,514, Advisory Action dated Oct. 23, 2008. |
U.S. Appl. No. 10/982,514, Advisory Action dated Sep. 22, 2008. |
U.S. Appl. No. 10/982,514, Final Office Action dated Feb. 1, 2008. |
U.S. Appl. No. 10/982,514, Non-Final Office Action dated Jul. 17, 2007. |
U.S. Appl. No. 10/982,514, Notice of Allowance dated Jan. 5, 2009. |
U.S. Appl. No. 10/982,514, Requirement for Restriction/Election dated Apr. 4, 2007. |
U.S. Appl. No. 12/416,435, Non-Final Office Action dated Mar. 22, 2011. |
U.S. Appl. No. 12/416,435, Notice of Allowance dated Oct. 17, 2011. |
U.S. Appl. No. 12/416,435, Restriction Requirement dated Dec. 10, 2010. |
U.S. Appl. No. 13/347,823, Non-Final Office Action dated Nov. 21, 2012. |
U.S. Appl. No. 13/347,823, Notice of Allowance dated Apr. 30, 2013. |
U.S. Appl. No. 13/347,823, Restriction Requirement dated Jul. 23, 2012. |
Vajo et. al., 2000, The Molecular and Genet.ic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis Nigricans, Endocrine Rev 21(1):23-39. |
Venkatesan et. al., 2004, Stimulation of proteoglycan synthesis by glucunosyltransferas-1 gene delivery: a strategy to promote cartilage repair, PNAS, 11(52):18087-92. |
Verbruggen et. al., 1985, Repair Function in Organ Cultured Human Cartilage. Replacement of Enzymatically Removed Proteoglycans During Long term Organ Culture, The Journal of Rheumatology, 12(4).665-674. |
Vidal et. al., 2005, Making sense of antisense, European Journal of Cancer, 41:2812-2818. |
Vunjak-Novakovic et. al., 1999, Bioreactor Cultivation Conditions Modulate the Composition and Mechanical Properties of Tissue-Engineered Cartilage; Journal of Orthopaedic Research, 17:130-138. |
Wade et. al., 1992, Codon usage tabulated from the GenBank genetic sequence data, Nucleic Acids Research, 20 (Supplernent):2111-2118. |
Walsh et. al., 2003, Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene, Gene, 307:111-123. |
Wang et. al., 1999, Overexpression of protein kinase C-? in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion, Journal of Cell Science, 112:3497-3506. |
Wells et. al., 1990, Additivity of Mutational Effects in Proteins Biochemistry, 29(37):8509. |
Wilson et. al., 1977, Biological Properties of Polio Virus Encapsulated in Lipio Vesicles, Proc Natl Acad Sci, 74(8):3471-3475. |
Winkler, 2013, Oligonucleotide conjugates for therapeutic applications, Ther Deliv., 4:791-809. |
Wise et. al., 2002, American Surgeon, 68(6):553-end. |
Wong et. al., 1995, Analysis of Putative Haparin-binding Domains of Fibroblast Growth Factor-1: Using Site-Directed Mutagenesis and Peptide Analogues, The Journal of Biological Chemistry, 270(43):25805-25811. |
Woods at. al., 2005, Effectiveness of three extraction techniques in the development decellularized bone-anterior cruciate ligament-bone graft, Biomaterials, 26:7339-7349. |
Written Opinion for PCT/IL2007/0011199, dated Sep. 16, 2008. |
Written Opinion of the International Searching Authority Application No. PCT/IL2004/000088, dated Aug. 18, 2004. |
Wu et. al., 2009, Multiple Synostoses Syndrome is Due to a Missense Mutation in Exon 2 of FGF9 Gene, The American Journal of Human Genetics, 85:53-63. |
Yamashita et. al., 2000, Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in The Ventrolateral Thalamic Nucleus of the Brain, Biochemical and Biophysical Research Communications, 277:494-498. |
Yang et. al., 1998, Improved fluorescence and dual color detection with enhanced blue and green variants of the green fluorescent protein, Journal of Biological Chemistry, 273:8212-6. |
Yang et. al., 2000, Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells, Immunity, 12(5):557-568. |
Yayon et, al., 1991, Cell Surface, Heparin-Like Molecules Are RequiredForBinding of Basic Fibroblast Growth Factor to Its High Affinity Receptor, Cell, 64:841-848. |
Yayon et, al., 1993, Isolation of peptides that inhibit binding of basic fibroblast growthfactor to its receptor from a random phage-epitope library, Proc. Natl. Acad. Sci. USA, 90:10643-10647. |
Yee et. al., 2000, Analysis of Fibroblast Growth Factor Receptor 3 S249C Mutation in Cervical Carcinoma, Journal of the National Cancer Institute, 92(22):1848-1849. |
Young's Modulus, Entry on http://enwikipecliaorg accessed Oct, 27, 2005, 3 pages. |
Zhang et. al., 1991, Three-dimensional structure of human basic fibroblast growth factor, a structural homology of interleukin 1 Beta, Proc. Natl. Acad. Sci. USA, 88(8):3446-3450. |
Zhang et. al., 1997, Directed evolution of a fucosidase from a galactosidase by DNA shuffling anti screening, Proc. Natl. Acad. Sci. USA, 94:4504-4509. |
Farndale et. al., 1982, A Direct Spectrophatometric Microassay for Sulfated Glycosaminoglycans in Carthage Cultures, Connective Tissue Research, 9(4):247-248. |
Feczko et. al., 2003, Experimental Results of Donor Site Filling for Autologous Osteochondral Mosaicplasty, Arthroscopy: The Journal of Arthroscopic and Related Surgery, 19(7):755-761. |
Final Office Action for U.S. Appl. No. 11/081,103, dated Aug. 11, 2010. |
Fingl et. al., 1975, The Pharmacological Basis of Therapeutics, Ch 1:1. |
Foldynova-Traritirkove et. al., 2012, Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias, Human Mutation, 33:29-41. |
Fujibayashi et. al., 2001, J Long Term Eff Med implants:11:93-103. |
Fujisato et. al., 1996, Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold, Biomaterials, 17:155-162. |
Furth, et. al., 1994, Temporal control of genexpression in transgenic mice by a tetracycline-responsive promoter, Proc Natl Acad Sci USA, 91:9302-9306. |
Gao et. al., 2002, Repair of Osteochondral Defect with Tissue-Engineered Two-Phase Composite Material Injectable Calcium Phosphate and Hyaluronan Sponge, Tissue Engineering Part A 8(5):827-837. |
Gargiulo et. al., 2002, Phenotypic modulation of human articular chondrocytes by bistratene A, Eur Cell Mater, 3:9-18. |
Garofalo et. al., 1999, Skeletal Dysplasia and Defective Chondrocyte Differentiation by targeted Overexpression of Fibroblast Growth Factor 9 in Transgenic Mice, Journal of Bone and Mineral Research, 14(11):1909-1915. |
George et. al., 2006, Differentiation of Mesenchymal Stem Cells Into Osteoblasts on Honeycomb Collagen Scaffoids, Artificial Organs, 25(3):180-186. |
George et. al., 2008, Biodegradable honeycomb collagen scaffold for dermal tissue engineering, J Biomed Mater Res 87A:1103-1111. |
Gertzman et. al., 2001, A pilot study evaluating sodium hyaluronate as a carrier for freeze-dried demineralized bone powder, Cell and Tissue Banking, 2:87-94. |
Gilbert et. at., 2006, Decellularization of Tissues and Organs, Biomaterials, 27(19):3675-3683. |
Givol et. al., 1992, Complexity of FGF receptors: genetic basis for structural diversity and functional specificity, FASEB J., 6:3362-3369. |
Glowacki et. al., 2001, Engineered Cartilage, Bone, Joints and Menisci-Potential for Temporomandibular Joint Reconstruction, Cells Tissues Organs, 189(3):302-308. |
Goldberg et. al., 2005, Intra-articular hyaluronans: the treatment knee pain in osteoarthritis, Osteoarthritis Cartilage, 13(3):216-224. |
Gooch et.al., 2001, IGF-I and Mechanical Environment Interact to Modulate Engineered Cartilage Development, Biochemical and Biophysical Research Communications, 286:909-915. |
Gruber et, al., 2002, Platelets stimulate proliferation of bone cells: involvement of platelet.derived growth factor, microparticles and membranes, Clin Oral Implants Res., 13(5):529-535. |
Guilak et. al., 2001, Functional tissue engineering: the role of biomechanics in articular cartilage repair. Clin Orthop Relat Res., (391 Suppl):S295-305. |
Haisch et. al., 2000, Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering, Cellular Engineering, Medical & Biological Engineering & Computing, 38:686-689. |
Hayes et. al., 2002, Combining computational and experimental screening for rapid optimization ofprotein properties, Proc Nati Aced Sci U S A, 99:15926-31. |
Hecht et. al., Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding inerfaces, Acta Crysallogr D Biol Crystallogr, 57:378-384. |
Herrera-Estrella et. al., 1983, Chimeric genes as dominant selectable markers in plant cells, EMBO J., 2(6):987-995. |
Hidaka et. al., 2003, Acceleration of cartilage repair by genetically modified chondrocytes overexpressing bone morphogenetic protein-7, J Orthop Res, 21(4):573-83. |
Hille et. al., 1990, Bleomycin resistance: a new dominant selectable marker for plant cell transformation, Plant Molecular Biology, 7:171-176. |
Hoffman, 2002, Hydrogels for Biomedical Applications, Advanced Drug Delivery Reviews, 54(1):3-12. |
Hromas et. al., 1993, Hematopoietic lineage-and stage-restricted expression the ETS oncogene family member PU.1, Blood 82:2998-3004. |
http://www.stoneclinic.com/articularcartilagepastegrafting (Copyright 2009). |
http://www.technobusiness-solutions.com/article-lyophilization1.html (published Feb. 12, 2002). |
Hunziker, 1992, Articular Cartilage Structure in Humans and Experimental Animals, Articular Cartilage and Osteoarthritis, Raven Press, ed:183-199. |
Hunziker, 1999, Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable?, Osteoarthritis and Cartilage 7(1):15-28. |
Hunziker, 2001, Articular Cartilage Repair: Basic Science and Clinical Progress A Review of the Current Status and Prospects, Osteoarthritis and Cartilage, 10(6):432-463. |
Ikeda et. al., 2000, Ex vivo gene delivery using an adenovirus vector in treatment for cartilage defects, J Rheumatol, 27(4):990-6. |
lmamura et. al., 1990, Recovery of Mitogenic Activity of a Growth Factor Mutant with a Nuclear Translocation Sequence, Science, 249:1567-1570. |
International Cartilage Repair Society, Cartilage Injury Evaluation Package, www.cartilage.org, 2000. |
International Preliminary Examination Report for PCT/US02/09001 dated Oct. 30, 2004, (7 pages). |
International Preliminary Report on Patentability Application No. PCT/IL2004/000088, dated Aug. 5, 2005. |
International Preliminary Report on Patentability for International Patent Application No. PCT/US2004/010956, dated Nov. 18, 2005. |
International Preliminary Report on Patentability for International Patent Application No. PCT/US2004/010957, dated Nov. 18, 2005. |
International Preliminary Report on Patentability for International Patent Application No. PCT/US2005/008798 dated Nov. 1, 2006. |
International Preliminary Report on Patentability for InternationalPatent Application No. PCT/US2005/030610, dated Feb. 26, 2008. |
International Preliminary Report on Patentability for International Patent Application No. PCT/US2005/036878, dated Apr. 17, 2007. |
International Preliminary Report on Patentability for International Patent Application No. PCT/US2008/051796, dated Jul. 28, 2009. |
International Preliminary Report on Patentability for PCT/IL2001/00962, dated Oct. 18, 2006. |
International Preliminary Report on Patentability for PCT/IL2007/001199 dated Mar. 21, 2009. |
International Preliminary Report on Patentability for PCT/US2008/073762 dated Feb. 24, 2010, (6 pages). |
International Preliminary Report on Patentability for PCT/US2009/001459, dated May 12, 2010. |
International Search Report and Written Opinion for international Patent Application No. PCT/US2004/010956, dated Oct. 28, 2005. |
Apr. 4, 2007 Requirement for Restriction/Election U.S. Appl. No. 10/982,514 (U.S. Pat. No. 7,563,769). |
Jul. 17, 2007 Non-Finai Rejection U.S. Appl. No. 10/982,514 (U.S. Pat. No. 7,563,769). |
Sep. 22, 2008 Advisory Action U.S. Appl. No. 10/982,514 (U.S. Pat. No. 7,563,769). |
Advisory Action dated Oct. 23, 2008 for U.S. Appl. No. 10/982,514. |
Advisory Action, dated Jun. 26, 2008, for U.S. Appl. No. 10/982,514. |
Advisory Action, dated Sep. 22, 2008, for U.S. Appl. No. 10/982,514. |
Final Office Action, dated Feb. 1, 2008, for U.S. Appl. No. 10/982,514. |
Non-Final Office Action, dated Dec. 15, 2006, for U.S. Appl. No. 10/895,961. |
Non-Final Office Action, dated Jul. 17, 2007, for U.S. Appl. No. 10/982,514. |
Non-Final Office Action, dated Jun. 20, 2005, for U.S. Appl. No. 10/761,615. |
A non-final Office Action dated Jan. 20, 2011 in connection with U.S. Appl. No. 12/381,072. |
A non-final Office Action dated Mar. 1, 2011 in connection with U.S. Appl. No. 12/924,132. |
Abbate et. al., 2001, Biotechniques 3 1:336-40. |
Abraham et. al., 1996, Human Basic Fibroblast Growth Factor: Nucleotide Sequence and Genomic Organization, EMBO Journal., 5(10):2523-2528. |
Agrawal et. al., 1991, Pharmacokinetics, Biodistribution, and Stabilityof Oligodeoxynucleotide Phosphorothioates in Mice, PNAS, 88:7595-7599. |
Altschul et. al., 1990, Basic Local Alignment Search Tool, J Mol Biol 215:403-410. |
Andres et. al., 2008, A Pro-Inflammatory Signature Mediates FGF2-nduced Angiogenesis, Journal of Cellular and Molecular Medicine, 13(8B):2083-2108. |
U.S. Appl. No. 11/190,387, Advisory Action, dated Dec. 16, 2008 (16 pages). |
U.S. Appl. No. 11/190,387, Advisory Action, dated Feb. 11, 2009 (7 pages). |
U.S. Appl. No. 11/190,387, Advisory Action, dated Jan. 14, 2008 (3 pages). |
U.S. Appl. No. 11/190,387, Advisory Action, dated Oct. 31. 2008 (15 pages). |
U.S. Appl. No. 11/190,387, Final Rejection, dated Aug. 26, 2008 (12 pages). |
U.S. Appl. No. 11/190,387, Final Rejection, dated Aug. 6, 2007 (18 pages). |
U.S. Appl. No. 11/190,387, Non-Finai Rejection, dated Mar. 27, 2007 (21 pages). |
U.S. Appl. No. 11/190,387, Non-Finai Rejection, dated Mar. 27, 2008 (11 pages). |
U.S. Appl. No. 11/190,387, Requirement for Restriction/Eiection, dated Sep. 7, 2006 (7 pages). |
U.S. Appl. No. 12/731,356, Non-Finai Rejection, dated Mar. 29, 2011 (14 pages). |
U.S. Appl. No. 12/731,356, Requirement for Restriction/Eiection, dated Dec. 23, 2010 (6 pages). |
Arai et. al., 2000, Gene delivery to human chondrocytes by an adeno associated virus vector J Rheumatol 27(4):979-82. |
Arai et. al., 2004, Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articuiar chondrocyte pellet culture system Osteoarthritis Cartilage, 8:599-613. |
Arakawa et. al., 1993, Production and Characterization of an Analog of Acidic Fibroblast Growth Factor With Enhanced Stability and Biological Activity, Protein Engineering, 6(5):541-546. |
Aston et ai., 1986, Repair of Articuiar Surfaces by Allografts of Articular and Growth-Plate Cartilage, Journal of Bone and Joint Surgery, 68-B(1):29-35. |
Attwood, 2000, The Babel of bioinfonmatics, Science, 290:471-473. |
Aviezer et. al., 1994, Differential Structural Requirements of Heparin and Heparan Sulfate Proteoglycans That Promote Binding of Basic Fibroblast Growth Factor To Its Receptor, The Journal of Biological Chemistry, 269(1):114-121. |
Aviles et. al., 2003, Testing clinical therapeutic angiogenesis using basic fibrobiast growth factor (FGF-2), British Journal of Pharmacology, 140:637-646. |
Bailly et. al., 2000, Uncoupling of Cell Proliferation and Differentiation Activities of Basic Fibroblast Growth Factor, FASEB Journal., 14:333-344. |
Baird, 1994, Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors, Current Opinions in Neurobioiogy, 4:78-86. |
Bange et. al., 2002, Cancer Progression and Tumor Cell Motility are Associated with the FGFR4 Arg 388 Allele, Cancer Research, 62:840-846. |
Baragi et. al., 1995, Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation, J. Ciin. Invest. 96(5):2454-60. |
Barralet et. al., 2000, Dissolution of dense carbonate apatite subcutaneously implanted in Wistar rats, J Biomed Mater Res, 49(2):176-82. |
Bartholomew et. al., 1997, The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation, Oncogene, 14:569-577. |
Behr et. al., 2010, Fgf-9 is required for angiogenesis and osteogenesis in long bone repair, PNAS, 107(26):11853-11858. |
Bellosta et. al., 2001, Identification of Receptor and Heparin Binding Sites in Fibrobiast Growth Factor 4 by Structure-Based Mutagenesis, Molecular and Cellular Biology 21(17):5946-5957. |
Ben-Bassat et. al., 2000, in Biomateriais Engineering and Devices: Human Applications v2:155-169. |
Berclaz et. al., 2002, regulates alveolar macrophage Fe?R-mediated phagocytosis and the IL-18/IFN?-mediated molecular connection between innate and adaptive immunity in the lung, Blood, 100:4193-4200. |
Beynnon et. al., 2005, Treatment of Anterior Cruciate Ligament Injuries Part 2, The American Journal of Sports Medicine, 33(11):1751-1767. |
Beynnon, et. al., 2005, Treatment of Anterior Cruciate Ligament Injuries Part 1, The American Journal of Sports Medicine, 33(10):1579-1602. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2004/010957, dated Nov. 1, 2004. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2005/008798, dated Jun. 19, 2006. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2005/030610, dated Apr. 7, 2006. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2005/036878, dated Sep. 21, 2006. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2008/085522, dated Jul. 6, 2009. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2008/001459, dated Jul. 6, 2009. |
International Search Report and Written Opinion for PCT/US2008/007610 dated Oct. 8, 2008. |
International Search Report and Written Opinion for PCT/US2010/000108 dated Aug. 24, 2010. |
International Search Report for PCT/IL02/00589 dated Mar. 26, 2003. |
International Search Report for PCT/US02/09001 dated Mar. 27, 2003, (2 pages). |
Itoh et. al., 2001, A Honeycomb Collagen Carrier for Cell Culture as a Tissue Engineering Scaffold, Artificial Organs, 25(3):213-217. |
Itokazu et. al., 1997, The Sustained Release of Antibiotic from Freeze-Dried Fibrin Antibiotic Compound and Efficacies in a Rat Model of Osteomyelitis, Infection, 25(6):359-363. |
Iwamoto et. al., 1991, Reduction in Basic Fibroblast Growth Factor Receptor is Coupled with Terminal Differentiation of Chondrocytes, J Biol Chem 266(1):461-467. |
Jackson et. al., 2001, Cartilage Substitute: Overview of Basic Science & Treatment Options, Journal of American Academy of Orthopaedic Surgeons, 9:37-52. |
Jacobi et. al., 2011, MACI—a new era?, Arthoscopy, Rehabilitation, Therapy & Technology, http://www.smartjournal.com/content/3/1/10. |
James et. al., 2000, Genetic manipulation of the rabbit heart via transgenesis, Circulation, 101:1715-1721. |
Johnson et. al., 1993, Structural and Frunctional Diversity in the FGF Receptor Multigene Family, Advances in Cancer Research, 60:1-41. |
Karlin et. al., 1990, Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes, Proc. Natl. Acad. Sci. USA, 87:2264-2268. |
Karlin et. al., 1993, Applications and statistics for multiple high-scoring segments in molecular sequences, Proc. Natl. Acad. Sci. USA, 90:5873-5877. |
Kastrup et. al., 1997, X-rat Structure of the 154-Amino-Acid Form of Recombinant Human Basic Fibroblast Growth Factor Comparison with the Truncated 146-Amino-Acid Form, Acta Crystallographica, Section D53:160-168. |
Kato et. al., 1990, Fibroblast Growth Factor is an Inhibitor of Chondrocyte Terminal Differentiation, Journal of Biological Chemistry, 265(10):5903-5909. |
Keegan et. al., 1991, Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3, Proc. Natl. Acad. Sci. USA, 88:1095-1099. |
Kiewitz et. al., 2009, Transcriptional regulation of S100A1 and exparession during mouse heart development, Biochim Biophys Acts, 1498:207-19. |
Kim et. al., 2002, Alternative type I and I? turn conformations in the ?8/?9 ?-hairpin of human acidic fibroblast growth factor, Protein Science, 11(3):459-66. |
Kirikoshi, 2000, Molecular Cloning and Characterization of Human FGF-20 on Chromosome 8p21.3-p22, Biochemical and Biophysical Research Communications, 274(2):337-343. |
Kirker et. al., 2002, Glycosaminoglycan Hydrogel Films as Biointeractive Dressings for Wound Healing, Biomaterials, 23:3661-3671. |
Kondo et. al., 2005, Effects of Administration of Exogenous Growth Factors on Biomechanical Properties of the Elongation-Type Anterior cruciate Ligament Infury With Partial Laceration, The American Journal of Sports Medicine, 33:188-196. |
Kunkel, 1985, Rapid and efficient site-specific mutagenesis without phenotypic selection, Proc. Natl. Acad. Sci. USA, 82:488-492. |
Kuroda et. al., 1999, Anabolic Effect of Amino terminally Truncated Fibroblast Growth Factor 4 (FGF4) on Bone, Bone, 25(4):431-437. |
Kurokawa et. al., 2000, The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death, EMBO J., 19:2958-2968. |
Kuroyanagi et. al., 2001, Tissue-Engineered Product: Allogeneic Cultured Dermal Subsitute Composed of Spongy Collagen with Fibroblasts, Artificial Organs, 25(3):180-186. |
Lakso et. al., 1992, Targeted oncogene activation by site-specific reombination in transgenic mice, Proc. Natl. Acad. Sci. USA, 89:6232-6236. |
LaPointe et. al., 1996, Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes, Hypertension, 27:715-722. |
Lev et. al., 1992, Dimerization and Activation of the Kit Receptor by Monovalent and Bivalent Binding of the Stem Cell Factor, The Journal of Biological Chemistry, 267, 15970-15977. |
Li et. al., 2004, Synthesis and biological evaluation of a cross-linked hyaluronan-mitomycin C hydrogel, Biomacromolecules, 5(3):895-902. |
Loeser et. al., 2005, Basic Fibroblast Growth Factor Inhibits the Anabolic Activity of Insulin-like Growth Factor 1 and Osteogenic Protein 1 in Adult Human Articular Chondrocytes, Arthritis & Rheumatism, 52(12):3910-3917. |
Lorget et. al., 2012, Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapituating Achondroplasis, Am J Hum Genet., 91(6):1108-1114. |
Lu et. al., 2006, Minced Cartilage without Cell Culture Serves as an Effective Intraoperative Cell Source for Carilage Repair, Journal of Orthopaedic Research, 24:1261-1270. |
Luo et. al., 1999, Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate, Bioconjugate Chemicals, 10(5):755-763. |
Madry et. al., 2003, Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system, J Gene Med, 5(6):502-9. |
Madry et. al., 2000, Efficient lipid-medicated gene transfer to articular chondrocytes, Gene Ther 7(4):286-91. |
Madry et. al., 2002, Gene Transfer of a Human Insulin-like Growth Factor I cDNA Enhances Tissue Engineering of Cartilage, Human Gene Therapy, 13:1621-1630. |
Madry et. al., 2003, Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage, Hum Gene Ther, 14(4):393-402. |
Marian et. al., 1999, A transgenic rabbit model for human hypertrophic cardiomyopathy, J Clin Invest., 104:1683-1692. |
Matsuda et. al., 1995, In Vivo Chrondrogenesis in Collagen Sponge Sandwiched by Perichondrium, J Biomater Sci Polymer Ed, 7(3):221-229. |
Mazue et. al., 1991, Preclinical and Clinical Studies with Recombinant Human Basic Fibroblast Growth Factor, Annals New York Academy of Sciences:329-340. |
Mbawuike et. al., 1989, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics, J Leukoc Biol., 46:119-127. |
McKercher et. al., 1996, Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities, EMBO J., 15:5647-5658. |
McLeskey et. al., 1994, MDA-MB-134 Breast Carcinoma Cells Overexpress Fibroblast Growth Factor (FGF) Receptors and Are Growth-Inhibited by FGF Ligands, Cancer Research 54(2):523-530. |
Messner et. al., 1996, Cartilage Repair: A Critical Review, Acta Orthopaedica Scandinavica, 67(5):523-529. |
Bikfalvi et al., 1997, Biological Roles of Fibroblast Growth Factor-2, Endocrine Reviews, 18(1):26-45. |
Blessing et. al., 1993, Transgenic mice as a model to study the role of TGF-beta-related molecules in hair follicles, Genes Dev, 7:204-215. |
Bolander, 1992, Regulation of fracture repair by growth factors, Proc Soc Exp Biol Med., 200(2):165-170. |
Bork et. al., 1996, Go hunting in sequence databases but watch out for the traps, Trends in Genetics 12(10):425-427. |
Bork, 2000, Powers and pitfaiis in sequence analysis: The 70% hurdle. Genome Res 10(4):398-400. |
Borok et. al., 2000, Differential regulation of rat aquaporin-5 promoter/enhancer activities in lung and salivary epithelial cells, J Biol Chem, 275:26507-14. |
Bradford, 1976, A Rapid and Sensitive Method for the Quantitation of Micro-gram Quantities of Protein Utilizing the Principle of Protein-Dye Binding, Analytical Biochemistry, 72(1-2):248-254. |
Bradley, 1987, Production and analysis of chimaeric mice. In Teratocarcinomas and Embryonic Stem Cells—A Practica Approach:113-152. |
Breinan et. el., 1997, Effect of Cultured Autologous Chondrocytes on Repair of Chondral Defects in a Canine Model, Journal of Bone and Joint Surgery [Am], 79-A(10):1439-1451. |
Breinan et al., 2001, Autologous Chondrocyte Implantation in a Canine Model: Change in Composition of Reparative Tissue with Time, Journal of Orthopaedic Research. 19:482-492. |
Brenner, 1999, Errors in genome annotation, Trends in Genetics 15(4):132-133. |
Brittberg et. al., 1994, Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte Transplantation, New England Journal of Medicine, 331(14):889-895. |
Brittberg et. al., 1996, Rabbit Articular Cartilage Defects Treated with Autologous Cultured Chondrocytes, Clinical Orthopaedics and Related Research, 326:270-283. |
Brittberg et. al., 2001, Autologous Chondrocytes Used for Articular Cartilage Repair: An Update, Clinical Orthopaedics and Related Research. 391 Suppl: S337-S348. |
Brown et. al., 2005, Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin, JEADV, 19(3):308-318. |
Buckwalter et. al., 1998, Articular Cartiiage; Degeneration and Osteoarthritis, Repair, Regeneration, and Transplantation, AAOS Instructional Course Lectures, 47:487-504. |
Bugbee, 2000, Fresh Osteochondral Allografting, Operative Techniques in Sports Medicine, 8(2):158-162. |
Bujard, 1999, Controlling genes with tetracyclines, J Gene Med, 1:372-374. |
Bulpitt et. al., 1999, New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels, J Biomed Mater Res, 47:152-169. |
Burdette et. al., 1996, Cloning and expression of the gene encoding the Thermoanaerobacter ethanaiicus 39E secondary-alcohol dehydrogenase and biochemical characterization of the enzyme, Biochem J, 316:115-122. |
Burger et. al., 2002, Fibroblast growth factor receptor-1 is expressed by endotheliai progenitor cells, Blood, 100(10):3527-35. |
Bursac, 2002, Collagen Network Contributions to Structure-Function Relationships in Cartilaginous Tissues in Compression (Dissertation), Boston University College of Engineering. |
Bystricky et. al., 2001, Nonbiodegradabie hyaluronan derivative prepared by reaction with a water-soluble carbodiimide Chem Paper, 1:49-52. |
Cappellen et. al., 1999, Frequent Activating Mutations Of FGFR3 In Human Bladder And Cervix Carcinomas, Nature Genetics, 23:18-20. |
Carr, 1988, Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen, Thromb Haemost., 59(3):535-539. |
Chalfie et. al., 1994, Green fluorescent protein as a marker for gene expression, Science 263:802-805. |
Charron et. al., 1999, Cooperative Interaction between GATA-4 and GATA-6 Regulates Myocardial Gens Expression, Molecular & Cellular Biology 19(6):4355-4365. |
Chellaiah et. al., 1994, Fibroblast Growth Factor Receptor (FGFR) 3. The Journal of Biological Chemistry 269(15):11620-11627. |
Chen et. al., 1999, Repair of Articular Cartilage Defects: Part I Basic Science of Cartilage Healing, The American Journal of Orthopedics:31-33. |
Chole et. al., 2001, JARO 2:65-71. |
Chusho et. al., 2001, Dwarfism and Early Death in Mice Lacking C-Type Natriuretic Peptide, PNAS, 98(7):4016-4021. |
Coffin et. al., 1997, Retroviruses Cold Spring Harber Laboratory Press:758-763. |
Coiombier et. al., 1999, Cells Tissues Organs 164:131-140. |
Communication pursuant to Article 94(3) EPC for European Patent Application No. 06814983.0, dated Sep. 23, 2013, 6 pages. |
Cook et. al., 2003, Biocompatibiiity of three-dimensional chondrocyte grafts in large tibial defects of rabbits, Am J Vet. Res 64(1):12-20. |
A Communication dated Oct. 9, 2007 in connection with U.S. Appl. No. 10/438,883. |
A final Office Action dated Dec. 28, 2009 in connection with U.S. Appl. No. 11/657,042. |
A final Office Action dated Jan. 7, 2010 in connection with U.S. Appl. No. 11/481,955. |
A final Office Action dated Mar. 15, 2010 in connection with U.S. Appl. No. 10/815,778. |
A final Office Action dated Nov. 13, 2008 in connection with U.S. Appl. No. 10/815,778. |
A final Office Action dated Oct. 18, 2005 in connection with U.S. Appl. No. 10/438,883. |
A final Office Action dated Sep. 19, 2008 in connection with U.S. Appl. No. 11/081,105. |
A final Office Action dated Sep. 28, 2007 in connection with U.S. Appl. No. 10/960,960. |
Advisory Action dated Dec. 27, 2007 in connection with U.S. Appl. No. 11/151,270. |
Final Office Action dated Mar. 22, 2010 in connection with U.S. Appl. No. 12/010,984. |
Final Office Action dated Oct. 9, 2007 In connection with U.S. Appl. No. 11/151,270. |
Non-Finai Office Action dated Apr. 12, 2010 in connection with U.S. Appl. No. 12/191,490. |
Non-Final Office Action dated Apr. 15, 2010 in connection with U.S. Appl. No. 11/657,042. |
Non-Final Office Action dated Apr. 15, 2010 in connection with U.S. Appl. No. 12/079,629. |
Non-Final Office Action dated Apr. 26, 2010 in connection with U.S. Appl. No. 12/147,042. |
Number | Date | Country | |
---|---|---|---|
20190010439 A1 | Jan 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14558080 | Dec 2014 | US |
Child | 16131234 | US |